709 IDENTIFICATION OF PREDICTING FACTORS FOR SEROCONVERSION OF HEPATITIS B E ANTIGEN WITHIN A YEAR AMONG BIOCHEMICAL, PATHOLOGICAL AND VIROLOGICAL MARKERS (English)
- New search for: Bae, S. K.
- New search for: Yatsuhashi, H.
- New search for: Yano, K.
- New search for: Fukuda, M.
- New search for: Nakao, R.
- New search for: Hamada, R.
- New search for: Hashimoto, S.
- New search for: Nishikawa, A.
- New search for: Motoyoshi, Y.
- New search for: Nagaoka, S.
- New search for: Bae, S. K.
- New search for: Yatsuhashi, H.
- New search for: Yano, K.
- New search for: Fukuda, M.
- New search for: Nakao, R.
- New search for: Hamada, R.
- New search for: Hashimoto, S.
- New search for: Nishikawa, A.
- New search for: Motoyoshi, Y.
- New search for: Nagaoka, S.
In:
JOURNAL OF HEPATOLOGY
;
52
;
S275-S276
;
2010
-
ISSN:
- Article (Journal) / Print
-
Title:709 IDENTIFICATION OF PREDICTING FACTORS FOR SEROCONVERSION OF HEPATITIS B E ANTIGEN WITHIN A YEAR AMONG BIOCHEMICAL, PATHOLOGICAL AND VIROLOGICAL MARKERS
-
Contributors:Bae, S. K. ( author ) / Yatsuhashi, H. ( author ) / Yano, K. ( author ) / Fukuda, M. ( author ) / Nakao, R. ( author ) / Hamada, R. ( author ) / Hashimoto, S. ( author ) / Nishikawa, A. ( author ) / Motoyoshi, Y. ( author ) / Nagaoka, S. ( author )
-
Published in:JOURNAL OF HEPATOLOGY ; 52 ; S275-S276
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam.
-
Publication date:2010-01-01
-
Size:S275-S276
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 616.3623
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 616.3623 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 52
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
EASL transitioning into the new decadeWedemeyer, Heiner et al. | 2010
- 3
-
FocusSamuel, Didier et al. | 2010
- 5
-
Welcome editorialSamuel, Didier et al. | 2010
- 7
-
Secondary peritonitis in cirrhosis: “Oil in fire”Wiest, Reiner / Schoelmerich, Juergen et al. | 2010
- 10
-
Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depressionSchafer, A. / Scheurlen, M. / Seufert, J. / Keicher, C. / Weibrich, B. / Rieger, P. / Kraus, M. R. et al. | 2010
- 16
-
Hepatic lipid profiling in chronic hepatitis C: An in vitro and in vivo proton magnetic resonance spectroscopy studyCobbold, Jeremy F.L. / Patel, Jaymin H. / Goldin, Robert D. / North, Bernard V. / Crossey, Mary M.E. / Fitzpatrick, Julie / Wylezinska, Marzena / Thomas, Howard C. / Cox, I. Jane / Taylor-Robinson, Simon D. et al. | 2010
- 25
-
Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: A meta-analysisMoreno, Christophe / Deltenre, Pierre / Pawlotsky, Jean-Michel / Henrion, Jean / Adler, Michael / Mathurin, Philippe et al. | 2010
- 32
-
Safety and efficacy of viramidine versus ribavirin in ViSER2: Randomized, double-blind study in therapy-naive hepatitis C patientsMarcellin, P. / Gish, R. G. / Gitlin, N. / Heise, J. / Halliman, D. G. / Chun, E. / Rodriguez-Torres, M. et al. | 2010
- 39
-
Secondary bacterial peritonitis in cirrhosis: A retrospective study of clinical and analytical characteristics, diagnosis and managementSoriano, G. / Castellote, J. / Alvarez, C. / Girbau, A. / Gordillo, J. / Baliellas, C. / Casas, M. / Pons, C. / Roman, E. M. / Maisterra, S. et al. | 2010
- 45
-
Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteriaMerkel, Carlo / Bolognesi, Massimo / Berzigotti, Annalisa / Amodio, Piero / Cavasin, Lucia / Casarotto, Ilaria Maria / Zoli, Marco / Gatta, Angelo et al. | 2010
- 54
-
ATP release after partial hepatectomy regulates liver regeneration in the ratGonzales, E. / Julien, B. / Serriere-Lanneau, V. / Nicou, A. / Doignon, I. / Lagoudakis, L. / Garcin, I. / Azoulay, D. / Duclos-Vallee, J. C. / Castaing, D. et al. | 2010
- 63
-
The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinomaAihara, Arihiro / Tanaka, Shinji / Yasen, Mahmut / Matsumura, Satoshi / Mitsunori, Yusuke / Murakata, Ayano / Noguchi, Norio / Kudo, Atsushi / Nakamura, Noriaki / Ito, Koji et al. | 2010
- 72
-
Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma developmentNakamoto, Shingo / Imazeki, Fumio / Fukai, Kenichi / Fujiwara, Keiichi / Arai, Makoto / Kanda, Tatsuo / Yonemitsu, Yutaka / Yokosuka, Osamu et al. | 2010
- 79
-
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)Huynh, Hung / Ngo, Van Chanh / Koong, Heng Nung / Poon, Donald / Choo, Su Pin / Toh, Han Chong / Thng, Choon Hua / Chow, Pierce / Ong, Hock Soo / Chung, Alexander et al. | 2010
- 88
-
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivationChen, K. F. / Yu, H. C. / Liu, T. H. / Lee, S. S. / Chen, P. J. / Cheng, A. L. et al. | 2010
- 96
-
Upregulation of hepatoma-derived growth factor is involved in murine hepatic fibrogenesisKao, Ying-Hsien / Chen, Chao-Long / Jawan, Bruno / Chung, Yueh-Hua / Sun, Cheuk-Kwan / Kuo, Shiao-Mei / Hu, Tsung-Hui / Lin, Yu-Chun / Chan, Hoi-Hung / Cheng, Kuang-Hung et al. | 2010
- 106
-
Characterisation and utility of thiopurine methyltransferase and thiopurine metabolite measurements in autoimmune hepatitisHindorf, U. / Jahed, K. / Bergquist, A. / Verbaan, H. / Prytz, H. / Wallerstedt, S. / Werner, M. / Olsson, R. / Bjornsson, E. / Peterson, C. et al. | 2010
- 112
-
Potential strategies to improve uptake of exercise interventions in non-alcoholic fatty liver diseaseFrith, J. / Day, C. P. / Robinson, L. / Elliott, C. / Jones, D. E. / Newton, J. L. et al. | 2010
- 117
-
The quest for liver progenitor cells: A practical point of viewDollé, Laurent / Best, Jan / Mei, Jie / Al Battah, Feras / Reynaert, Hendrik / van Grunsven, Leo A. / Geerts, Albert et al. | 2010
- 130
-
CD8+ T cells drive adipose tissue inflammation - A novel clue for NASH pathogenesis?Popov, Y. / Schuppan, D. et al. | 2010
- 133
-
PEG IFN alfa-2a vs. alfa-2b: And the winner is ?Craxi, A. et al. | 2010
- 136
-
Immune-mediated liver injuryLohse, A. W. / Weiler-Normann, C. / Tiegs, G. et al. | 2010
- 147
-
Entecavir in decompensated HBV cirrhosis: The future is looking brighterFontana, R. J. et al. | 2010
- 150
-
Will nano-fibers permit to turn liver cell transplantation into a curative tool against liver failure?Moniaux, N. / Faivre, J. et al. | 2010
- 153
-
Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis CGrunhage, F. / Nattermann, J. / Gressner, O. A. / Wasmuth, H. E. / Hellerbrand, C. / Sauerbruch, T. / Spengler, U. / Lammert, F. et al. | 2010
- 160
-
Hepatitis C virus viremia and low platelet count: A study in a hepatitis B & C endemic area in TaiwanDai, C. Y. / Ho, C. K. / Huang, J. F. / Hsieh, M. Y. / Hou, N. J. / Lin, Z. Y. / Chen, S. C. / Wang, L. Y. / Chang, W. Y. et al. | 2010
- 167
-
Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 proteaseJouan, L. / Melancon, P. / Rodrigue-Gervais, I. G. / Raymond, V. A. / Selliah, S. / Boucher, G. / Bilodeau, M. / Grandvaux, N. / Lamarre, D. et al. | 2010
- 176
-
Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosisShim, J. H. / Lee, H. C. / Kim, K. M. / Lim, Y. S. / Chung, Y. H. / Lee, Y. S. / Suh, D. J. et al. | 2010
- 183
-
Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infectionCrotta, S. / Brazzoli, M. / Piccioli, D. / Valiante, N. M. / Wack, A. et al. | 2010
- 191
-
Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis CCastera, L. / Sebastiani, G. / Le Bail, B. / de Ledinghen, V. / Couzigou, P. / Alberti, A. et al. | 2010
- 199
-
Effects of antibiotics on expression and function of Toll-like receptors 2 and 4 on mononuclear cells in patients with advanced cirrhosisTestro, A. G. / Gow, P. J. / Angus, P. W. / Wongseelashote, S. / Skinner, N. / Markovska, V. / Visvanathan, K. et al. | 2010
- 206
-
Liver stiffness is directly influenced by central venous pressureMillonig, G. / Friedrich, S. / Adolf, S. / Fonouni, H. / Golriz, M. / Mehrabi, A. / Stiefel, P. / Poschl, G. / Buchler, M. W. / Seitz, H. K. et al. | 2010
- 211
-
Intramuscular transplantation of engineered hepatic tissue constructs corrects acute and chronic liver failure in miceNavarro-Alvarez, N. / Soto-Gutierrez, A. / Chen, Y. / Caballero-Corbalan, J. / Hassan, W. / Kobayashi, S. / Kondo, Y. / Iwamuro, M. / Yamamoto, K. / Kondo, E. et al. | 2010
- 220
-
Identification and expression analysis of the aldo-ketoreductase1-B10 gene in primary malignant liver tumoursHeringlake, S. / Hofdmann, M. / Fiebeler, A. / Manns, M. P. / Schmiegel, W. / Tannapfel, A. et al. | 2010
- 228
-
A new NMR-based metabolomics approach for the diagnosis of biliary tract cancerWen, H. / Yoo, S. S. / Kang, J. / Kim, H. G. / Park, J. S. / Jeong, S. / Lee, J. I. / Kwon, H. N. / Kang, S. / Lee, D. H. et al. | 2010
- 234
-
Proteomic analysis reveals a major role for contact inhibition in the terminal differentiation of hepatocytesMancone, C. / Conti, B. / Amicone, L. / Bordoni, V. / Cicchini, C. / Calvo, L. / Perdomo, A. B. / Fimia, G. M. / Tripodi, M. / Alonzi, T. et al. | 2010
- 244
-
The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid statusHoekstra, M. / Li, Z. / Kruijt, J. K. / Eck, M. V. / Berkel, T. J. / Kuiper, J. et al. | 2010
- 252
-
Risk of HCC: Genetic heterogeneity and complex geneticsDragani, T. A. et al. | 2010
- 258
-
Liver disease associated with canalicular transport defects: Current and future therapiesStapelbroek, J. M. / van Erpecum, K. J. / Klomp, L. W. / Houwen, R. H. et al. | 2010
- 272
-
Liver grafts from anti-hepatitis B core positive donors: A systematic reviewCholongitas, E. / Papatheodoridis, G. V. / Burroughs, A. K. et al. | 2010
- 280
-
EpCAM, a new marker for cancer stem cells in hepatocellular carcinomaTerris, B. / Cavard, C. / Perret, C. et al. | 2010
- 282
-
The replication cycle of hepatitis B virusUrban, S. / Schulze, A. / Dandri, M. / Petersen, J. et al. | 2010
- 285
-
NF-kB signalling: Embracing complexity to achieve translationChakraborty, J. B. / Mann, D. A. et al. | 2010
- 292
-
Adult-onset ornithine transcarbamylase (OTC) deficiency unmasked by the Atkins' dietBen-Ari, Z. / Dalal, A. / Morry, A. / Pitlik, S. / Zinger, P. / Cohen, J. / Fattal, I. / Galili-Mosberg, R. / Tessler, D. / Baruch, R. G. et al. | 2010
- 296
-
Liver cancer: From molecular pathogenesis to new therapies:Summary of the EASL single topic conferenceDufour, J. F. / Johnson, P. et al. | 2010
- 305
-
Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: A clarificationGrasso, A. et al. | 2010
- 305
-
Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: Some issuesWu, K. T. / Yang, J. F. / Chuang, W. L. / Yu, M. L. et al. | 2010
- 306
-
Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patientsDonato, C. / Cingolani, A. / Pinnetti, C. / De Luca, A. et al. | 2010
- 310
-
Ablation for hepatocellular carcinoma: Is there need to have a winning technique?Forner, A. / Bruix, J. et al. | 2010
- 313
-
Harmony in liver fibrosisBedossa, P. et al. | 2010
- 315
-
Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosisClaassen, M. A. / de Knegt, R. J. / Tilanus, H. W. / Janssen, H. L. / Boonstra, A. et al. | 2010
- 322
-
T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis BJu, Y. / Hou, N. / Meng, J. / Wang, X. / Zhang, X. / Zhao, D. / Liu, Y. / Zhu, F. / Zhang, L. / Sun, W. et al. | 2010
- 330
-
A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis BTan, A. T. / Koh, S. / Goh, W. / Zhe, H. Y. / Gehring, A. J. / Lim, S. G. / Bertoletti, A. et al. | 2010
- 340
-
The use of b-adrenergic drugs improves hepatic oxygen metabolism in cirrhotic patients undergoing liver resectionTaura, P. / Fuster, J. / Mercadal, J. / Martinez-Palli, G. / Fondevila, C. / Blasi, A. / Balust, J. / Garcia-Valdecasas, J. C. et al. | 2010
- 348
-
Encephalopathy assessment in children with extra-hepatic portal vein obstruction with MR, psychometry and critical flicker frequencyYadav, S. K. / Srivastava, A. / Thomas, M. A. / Agarwal, J. / Pandey, C. M. / Lal, R. / Yachha, S. K. / Saraswat, V. A. / Gupta, R. K. et al. | 2010
- 355
-
Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation testsLisman, T. / Bakhtiari, K. / Pereboom, I. T. / Hendriks, H. G. / Meijers, J. C. / Porte, R. J. et al. | 2010
- 362
-
The avb6 integrin is a highly specific immunohistochemical marker for cholangiocarcinomaPatsenker, E. / Wilkens, L. / Banz, V. / Osterreicher, C. H. / Weimann, R. / Eisele, S. / Keogh, A. / Stroka, D. / Zimmermann, A. / Stickel, F. et al. | 2010
- 370
-
Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patientsChew, V. / Tow, C. / Teo, M. / Wong, H. L. / Chan, J. / Gehring, A. / Loh, M. / Bolze, A. / Quek, R. / Lee, V. K. et al. | 2010
- 380
-
Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: A meta-analysisGermani, G. / Pleguezuelo, M. / Gurusamy, K. / Meyer, T. / Isgro, G. / Burroughs, A. K. et al. | 2010
- 389
-
Advanced glycation end products induce production of reactive oxygen species via the activation of NADPH oxidase in murine hepatic stellate cellsGuimaraes, E. L. / Empsen, C. / Geerts, A. / van Grunsven, L. A. et al. | 2010
- 398
-
Fibrillar collagen scoring by second harmonic microscopy: A new tool in the assessment of liver fibrosisGailhouste, L. / Grand, Y. L. / Odin, C. / Guyader, D. / Turlin, B. / Ezan, F. / Desille, Y. / Guilbert, T. / Bessard, A. / Fremin, C. et al. | 2010
- 407
-
TGF-b enhances alcohol dependent hepatocyte damage via down-regulation of alcohol dehydrogenase ICiuclan, L. / Ehnert, S. / Ilkavets, I. / Weng, H. L. / Gaitantzi, H. / Tsukamoto, H. / Ueberham, E. / Meindl-Beinker, N. M. / Singer, M. V. / Breitkopf, K. et al. | 2010
- 417
-
Porphobilinogen deaminase over-expression in hepatocytes, but not in erythrocytes, prevents accumulation of toxic porphyrin precursors in a mouse model of acute intermittent porphyriaUnzu, C. / Sampedro, A. / Mauleon, I. / Vanrell, L. / Dubrot, J. / de Salamanca, R. E. / Gonzalez-Aseguinolaza, G. / Melero, I. / Prieto, J. / Fontanellas, A. et al. | 2010
- 425
-
Iron uptake from plasma transferrin by a transferrin receptor 2 mutant mouse model of haemochromatosisChua, A. C. / Delima, R. D. / Morgan, E. H. / Herbison, C. E. / Tirnitz-Parker, J. E. / Graham, R. M. / Fleming, R. E. / Britton, R. S. / Bacon, B. R. / Olynyk, J. K. et al. | 2010
- 432
-
Congenital disorders of glycosylation in hepatology: The example of polycystic liver diseaseJanssen, M. J. / Waanders, E. / Woudenberg, J. / Lefeber, D. J. / Drenth, J. P. et al. | 2010
- 441
-
Is response to antiviral treatment influenced by hepatitis B virus genotype?Raimondi, S. / Maisonneuve, P. / Bruno, S. / Mondelli, M. U. et al. | 2010
- 450
-
International HepatologyGlaser, S. S. / Alpini, G. et al. | 2010
- 452
-
Genetic polymorphism and response to treatment in chronic hepatitis C: The future of personalized medicineAsselah, T. et al. | 2010
- 455
-
The new therapeutic frontier - Nuclear receptors and the liverKarpen, S. J. / Trauner, M. et al. | 2010
- 463
-
Reactivation of hepatitis B virus after transarterial chemo-embolization for hepatocellular carcinoma in one patient with negative hepatitis B surface antigenHung, H. H. / Su, C. W. / Wu, J. C. / Lee, S. D. et al. | 2010
- 466
-
Corrigendum to "Acute hepatitis caused by a natural lipid-lowering product: When "alternative" medicine is no "alternative" at all" [J Hepatol 50 (2009) 1273-1277]Grieco, A. / Miele, L. / Pompili, M. / Biolato, M. / Vecchio, F. M. / Grattagliano, I. / Gasbarrini, G. et al. | 2010
- 469
-
Ribavirin ante portas: Uptake transporters into hepatocytes dissectedBengsch, B. / Thimme, R. et al. | 2010
- 472
-
Treatment of chronic hepatitis C in children: Is it necessary and, if so, in whom?Alisi, A. / Comparcola, D. / Nobili, V. et al. | 2010
- 475
-
A new role for an old marker, HBsAgBrunetto, M. R. et al. | 2010
- 478
-
Evolution of full-length HBV sequences in chronic hepatitis B patients with sequential lamivudine and adefovir dipivoxil resistanceChen, C. H. / Lee, C. M. / Tung, W. C. / Wang, J. H. / Hung, C. H. / Hu, T. H. / Wang, J. C. / Lu, S. N. / Changchien, C. S. et al. | 2010
- 486
-
Characterization of ribavirin uptake systems in human hepatocytesFukuchi, Y. / Furihata, T. / Hashizume, M. / Iikura, M. / Chiba, K. et al. | 2010
- 493
-
Antiviral effect of entecavir in chronic hepatitis B: Influence of prior exposure to nucleos(t)ide analoguesReijnders, J. G. / Deterding, K. / Petersen, J. / Zoulim, F. / Santantonio, T. / Buti, M. / van Bommel, F. / Hansen, B. E. / Wedemeyer, H. / Janssen, H. L. et al. | 2010
- 501
-
High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirinWirth, S. / Ribes-Koninckx, C. / Calzado, M. A. / Bortolotti, F. / Zancan, L. / Jara, P. / Shelton, M. / Kerkar, N. / Galoppo, M. / Pedreira, A. et al. | 2010
- 508
-
Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: A perspective on AsiaNguyen, T. / Thompson, A. J. / Bowden, S. / Croagh, C. / Bell, S. / Desmond, P. V. / Levy, M. / Locarnini, S. A. et al. | 2010
- 514
-
Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: A European perspectiveJaroszewicz, J. / Serrano, B. C. / Wursthorn, K. / Deterding, K. / Schlue, J. / Raupach, R. / Flisiak, R. / Bock, C. T. / Manns, M. P. / Wedemeyer, H. et al. | 2010
- 523
-
Serum sodium, renal function, and survival of patients with end-stage liver diseaseLim, Y. S. / Larson, T. S. / Benson, J. T. / Kamath, P. S. / Kremers, W. K. / Therneau, T. M. / Kim, W. R. et al. | 2010
- 529
-
Relevance of the mTOR signaling pathway in the pathophysiology of splenomegaly in rats with chronic portal hypertensionMejias, M. / Garcia-Pras, E. / Gallego, J. / Mendez, R. / Bosch, J. / Fernandez, M. et al. | 2010
- 540
-
Impaired liver regeneration of steatotic rats after portal vein ligation: A particular emphasis on 99mTc-DISIDA scintigraphy and adiponectin signalingHsiao, I. T. / Lin, K. J. / Chang, S. I. / Yen, T. C. / Chen, T. C. / Yeh, T. S. et al. | 2010
- 550
-
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockageTovar, V. / Alsinet, C. / Villanueva, A. / Hoshida, Y. / Chiang, D. Y. / Sole, M. / Thung, S. / Moyano, S. / Toffanin, S. / Minguez, B. et al. | 2010
- 560
-
Reperfusion stress induced during intermittent selective clamping accelerates rat liver regeneration through JNK pathwayDuval, H. / Mbatchi, S. F. / Grandadam, S. / Legendre, C. / Loyer, P. / Ribault, C. / Piquet-Pellorce, C. / Guguen-Guillouzo, C. / Boudjema, K. / Corlu, A. et al. | 2010
- 570
-
Regulation of the human bile acid UDP-glucuronosyltransferase 1A3 by the farnesoid X receptor and bile acidsErichsen, T. J. / Aehlen, A. / Ehmer, U. / Kalthoff, S. / Manns, M. P. / Strassburg, C. P. et al. | 2010
- 579
-
Non-invasive assessment of hepatic steatosis: Prospective comparison of the accuracy of imaging examinationsLee, S. S. / Park, S. H. / Kim, H. J. / Kim, S. Y. / Kim, M. Y. / Kim, D. Y. / Suh, D. J. / Kim, K. M. / Bae, M. H. / Lee, J. Y. et al. | 2010
- 586
-
Palmitoleate attenuates palmitate-induced Bim and PUMA up-regulation and hepatocyte lipoapoptosisAkazawa, Y. / Cazanave, S. / Mott, J. L. / Elmi, N. / Bronk, S. F. / Kohno, S. / Charlton, M. R. / Gores, G. J. et al. | 2010
- 594
-
Mechanisms of HBV-related hepatocarcinogenesisNeuveut, C. / Wei, Y. / Buendia, M. A. et al. | 2010
- 605
-
The evaluation of renal function and disease in patients with cirrhosisFrancoz, C. / Glotz, D. / Moreau, R. / Durand, F. et al. | 2010
- 614
-
Serological Surveillance for hepatocellular carcinoma: Time to quitSherman, M. et al. | 2010
- 616
-
The molecular basis of the failed immune response in chronic HBV: Therapeutic implicationsMaini, M. K. / Schurich, A. et al. | 2010
- 620
-
Corrigendum to: "Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development" [J Hepatol 2010;52:72-78]Nakamoto, S. / Imazeki, F. / Fukai, K. / Fujiwara, K. / Arai, M. / Kanda, T. / Yonemitsu, Y. / Yokosuka, O. et al. | 2010
- 622
-
Renal function and MELD: Being direct is betterGonzalez, S. A. / Trotter, J. F. et al. | 2010
- 624
-
Treating hepatitis C in patients with cirrhosis: The effort is worth itForns, X. / Bruix, J. et al. | 2010
- 627
-
Re-emerging interest in hepatitis delta: New insights into the dynamic interplay between HBV and HDVWedemeyer, H. et al. | 2010
- 630
-
Are viral or host factors predictive of response to interferon-ribavirin in transplant patients with hepatitis C?Roche, B. / Samuel, D. et al. | 2010
- 633
-
New therapeutic targets in HCC: Reptin ATPase and HCC senescenceBerasain, C. et al. | 2010
- 635
-
The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8Clement, S. / Pascarella, S. / Conzelmann, S. / Gonelle-Gispert, C. / Guilloux, K. / Negro, F. et al. | 2010
- 644
-
The scavenger receptors SRA-1 and SREC-I cooperate with TLR2 in the recognition of the hepatitis C virus non-structural protein 3 by dendritic cellsBeauvillain, C. / Meloni, F. / Sirard, J. C. / Blanchard, S. / Jarry, U. / Scotet, M. / Magistrelli, G. / Delneste, Y. / Barnaba, V. / Jeannin, P. et al. | 2010
- 652
-
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosisCardoso, A. C. / Moucari, R. / Figueiredo-Mendes, C. / Ripault, M. P. / Giuily, N. / Castelnau, C. / Boyer, N. / Asselah, T. / Martinot-Peignoux, M. / Maylin, S. et al. | 2010
- 658
-
Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and DSchaper, M. / Rodriguez-Frias, F. / Jardi, R. / Tabernero, D. / Homs, M. / Ruiz, G. / Quer, J. / Esteban, R. / Buti, M. et al. | 2010
- 665
-
Use of desirability functions to evaluate health status in patients with cirrhosisGennings, C. / Heuman, D. / Fulton, O. / Sanyal, A. J. et al. | 2010
- 672
-
Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantationFukuhara, T. / Taketomi, A. / Okano, S. / Ikegami, T. / Soejima, Y. / Shirabe, K. / Maehara, Y. et al. | 2010
- 681
-
In vivo silencing of Reptin blocks the progression of human hepatocellular carcinoma in xenografts and is associated with replicative senescenceMenard, L. / Taras, D. / Grigoletto, A. / Haurie, V. / Nicou, A. / Dugot-Senant, N. / Costet, P. / Rousseau, B. / Rosenbaum, J. et al. | 2010
- 690
-
Let-7g targets collagen type I a2 and inhibits cell migration in hepatocellular carcinomaJi, J. / Zhao, L. / Budhu, A. / Forgues, M. / Jia, H. L. / Qin, L. X. / Ye, Q. H. / Yu, J. / Shi, X. / Tang, Z. Y. et al. | 2010
- 698
-
The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinomaShimizu, S. / Takehara, T. / Hikita, H. / Kodama, T. / Miyagi, T. / Hosui, A. / Tatsumi, T. / Ishida, H. / Noda, T. / Nagano, H. et al. | 2010
- 705
-
Bile acids modulate glucocorticoid metabolism and the hypothalamic-pituitary-adrenal axis in obstructive jaundiceMcNeilly, A. D. / Macfarlane, D. P. / O'Flaherty, E. / Livingstone, D. E. / Mitic, T. / McConnell, K. M. / McKenzie, S. M. / Davies, E. / Reynolds, R. M. / Thiesson, H. C. et al. | 2010
- 712
-
Genetic associations in Italian primary sclerosing cholangitis: Heterogeneity across Europe defines a critical role for HLA-CHov, J. R. / Lleo, A. / Selmi, C. / Woldseth, B. / Fabris, L. / Strazzabosco, M. / Karlsen, T. H. / Invernizzi, P. et al. | 2010
- 718
-
Post-natal paucity of regulatory T cells and control of NK cell activation in experimental biliary atresiaMiethke, A. G. / Saxena, V. / Shivakumar, P. / Sabla, G. E. / Simmons, J. / Chougnet, C. A. et al. | 2010
- 727
-
Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent modelRector, R. S. / Thyfault, J. P. / Uptergrove, G. M. / Morris, E. M. / Naples, S. P. / Borengasser, S. J. / Mikus, C. R. / Laye, M. J. / Laughlin, M. H. / Booth, F. W. et al. | 2010
- 737
-
Unexpected effects of fasting on murine lipid homeostasis - Transcriptomic and lipid profilingSokolovic, M. / Sokolovic, A. / van Roomen, C. P. / Gruber, A. / Ottenhoff, R. / Scheij, S. / Hakvoort, T. B. / Lamers, W. H. / Groen, A. K. et al. | 2010
- 745
-
Primary biliary cirrhosis: A 2010 updatePoupon, R. et al. | 2010
- 759
-
The place of liver transplantation in the treatment of severe alcoholic hepatitisDureja, P. / Lucey, M. R. et al. | 2010
- 765
-
Foxa1 and Foxa2 regulate bile duct development in miceStrazzabosco, M. et al. | 2010
- 768
-
No inflammation? No cancer! Clear HBV early and live happilyVilla, E. / Fattovich, G. et al. | 2010
- 771
-
Personalized molecular targeted therapy in advanced, recurrent hepatocellular carcinoma after liver transplantation: A proof of principleBhoori, S. / Toffanin, S. / Sposito, C. / Germini, A. / Pellegrinelli, A. / Lampis, A. / Mazzaferro, V. et al. | 2010
- 776
-
Vinyl chloride and the liver: Misrepresentation of epidemiological evidenceMastrangelo, G. / Martines, D. / Fedeli, U. et al. | 2010
- 777
-
Selective rather than routine approach to endosopic retrograde cholangio-pancreatography in diagnosis of biliary atresiaHadzic, N. / Harrison, P. M. et al. | 2010
- 778
-
Surrogate endpoints and non-inferiority trials in chronic viral hepatitisGentile, I. / Borgia, G. et al. | 2010
- 779
-
Corrigendum to "Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury" [J Hepatol 49 (2008) 88-98]Douglass, A. / Wallace, K. / Parr, R. / Park, J. / Durward, E. / Broadbent, I. / Barelle, C. / Porter, A. J. / Wright, M. C. et al. | 2010
- 783
-
More sensitive hepatitis C virus RNA detection: What for?Pawlotsky, J. M. et al. | 2010
- 786
-
Diagnosing cirrhosis non-invasively: Sense the stiffness but don't forget the nodules!Castera, L. et al. | 2010
- 788
-
Programming, metabolic syndrome, and NAFLD: The challenge of transforming a vicious cycle into a virtuous cycleNobili, V. / Cianfarani, S. / Agostoni, C. et al. | 2010
- 791
-
Long-term use of entecavir in nucleoside-naive Japanese patients with chronic hepatitis B infectionYokosuka, O. / Takaguchi, K. / Fujioka, S. / Shindo, M. / Chayama, K. / Kobashi, H. / Hayashi, N. / Sato, C. / Kiyosawa, K. / Tanikawa, K. et al. | 2010
- 800
-
Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154Mueller, M. / Spangenberg, H. C. / Kersting, N. / Altay, T. / Blum, H. E. / Klenerman, P. / Thimme, R. / Semmo, N. et al. | 2010
- 812
-
Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapyHofer, H. / Donnerer, J. / Sator, K. / Staufer, K. / Scherzer, T. M. / Dejaco, C. / Sator, M. / Kessler, H. / Ferenci, P. et al. | 2010
- 817
-
Quantitative assessment of the antiviral potencies of 21 shRNA vectors targeting conserved, including structured, hepatitis B virus sitesSun, D. / Rosler, C. / Kidd-Ljunggren, K. / Nassal, M. et al. | 2010
- 827
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescentsSokal, E. M. / Bourgois, A. / Stephenne, X. / Silveira, T. / Porta, G. / Gardovska, D. / Fischler, B. / Kelly, D. et al. | 2010
- 832
-
Definition of rapid virologic response with a highly sensitive real-time PCR-based HCV RNA assay in peginterferon alfa-2a plus ribavirin response-guided therapySarrazin, C. / Shiffman, M. L. / Hadziyannis, S. J. / Lin, A. / Colucci, G. / Ishida, H. / Zeuzem, S. et al. | 2010
- 839
-
Assessment of adrenal function in cirrhotic patients: Salivary cortisol should be preferredGalbois, A. / Rudler, M. / Massard, J. / Fulla, Y. / Bennani, A. / Bonnefont-Rousselot, D. / Thibault, V. / Reignier, S. / Bourrier, A. / Poynard, T. et al. | 2010
- 846
-
Ultrasonographic evaluation of liver surface and transient elastography in clinically doubtful cirrhosisBerzigotti, A. / Abraldes, J. G. / Tandon, P. / Erice, E. / Gilabert, R. / Garcia-Pagan, J. C. / Bosch, J. et al. | 2010
- 854
-
The polycomb group gene product Ezh2 regulates proliferation and differentiation of murine hepatic stem/progenitor cellsAoki, R. / Chiba, T. / Miyagi, S. / Negishi, M. / Konuma, T. / Taniguchi, H. / Ogawa, M. / Yokosuka, O. / Iwama, A. et al. | 2010
- 864
-
p53-insensitive PUMA down-regulation is essential in the early phase of liver regeneration after partial hepatectomy in miceChen, S. / Zheng, J. / Hao, Q. / Yang, S. / Wang, J. / Chen, H. / Chen, L. / Zhou, Y. / Yu, C. / Jiao, B. et al. | 2010
- 872
-
Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinomaKohga, K. / Tatsumi, T. / Takehara, T. / Tsunematsu, H. / Shimizu, S. / Yamamoto, M. / Sasakawa, A. / Miyagi, T. / Hayashi, N. et al. | 2010
- 880
-
Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: A pilot studyCucchetti, A. / Piscaglia, F. / Grigioni, A. D. / Ravaioli, M. / Cescon, M. / Zanello, M. / Grazi, G. L. / Golfieri, R. / Grigioni, W. F. / Pinna, A. D. et al. | 2010
- 889
-
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approachShen, Y. C. / Hsu, C. / Chen, L. T. / Cheng, C. C. / Hu, F. C. / Cheng, A. L. et al. | 2010
- 895
-
Harmful effect of adipose tissue on liver lesions in patients with alcoholic liver diseaseNaveau, S. / Cassard-Doulcier, A. M. / Njike-Nakseu, M. / Bouchet-Delbos, L. / Barri-Ova, N. / Boujedidi, H. / Dauvois, B. / Balian, A. / Maitre, S. / Prevot, S. et al. | 2010
- 903
-
Involvement of microsomal triglyceride transfer protein in nonalcoholic steatohepatitis in novel spontaneous mouse modelShindo, N. / Fujisawa, T. / Sugimoto, K. / Nojima, K. / Oze-Fukai, A. / Yoshikawa, Y. / Wang, X. / Yasuda, O. / Ikegami, H. / Rakugi, H. et al. | 2010
- 913
-
Maternal obesity during pregnancy and lactation programs the development of offspring non-alcoholic fatty liver disease in miceOben, J. A. / Mouralidarane, A. / Samuelsson, A. M. / Matthews, P. J. / Morgan, M. L. / Mckee, C. / Soeda, J. / Fernandez-Twinn, D. S. / Martin-Gronert, M. S. / Ozanne, S. E. et al. | 2010
- 921
-
Cancer gene discovery in hepatocellular carcinomaZender, L. / Villanueva, A. / Tovar, V. / Sia, D. / Chiang, D. Y. / Llovet, J. M. et al. | 2010
- 930
-
The place of downstaging for hepatocellular carcinomaToso, C. / Mentha, G. / Kneteman, N. M. / Majno, P. et al. | 2010
- 937
-
A new life for bile acidsJansen, P. L. et al. | 2010
- 939
-
The resurrection of alphafetoproteinSherman, M. et al. | 2010
- 941
-
Adenosine: Tipping the balance towards hepatic steatosis and fibrosisRobson, S. C. / Schuppan, D. et al. | 2010
- 944
-
Primary prophylaxis of esophageal variceal bleeding: An endoscopic approachLaine, L. et al. | 2010
- 946
-
Primary prevention of variceal haemorrhage: A pharmacological approachBurroughs, A. K. / Tsochatzis, E. A. / Triantos, C. et al. | 2010
- 949
-
Fibrogenic signalling in hepatic stellate cellsMann, D. A. / Marra, F. et al. | 2010
- 951
-
Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapyNeumann, U. P. / Biermer, M. / Eurich, D. / Neuhaus, P. / Berg, T. et al. | 2010
- 952
-
Combination of acarbose and ezetimibe prevents non-alcoholic fatty liver disease: A break of intestinal insulin resistance?Rudovich, N. N. / Weickert, M. O. / Machann, J. / Pfeiffer, A. F. et al. | 2010
- 954
-
Re: Soft drink consumption is associated with fatty liver disease independent of metabolic syndromeRotimi, O. et al. | 2010
- 954
-
Rebuttal to the Letter to the Editor by RotimiAssy, N. et al. | 2010
- II
-
Guide for Authors| 2010
- III
-
Volume Contents| 2010
- ix
-
Contents| 2010
- S1
-
2 FARNESOID-X RECEPTOR AGONISTS: A NEW CLASS OF DRUGS FOR THE TREATMENT OF PBC? AN INTERNATIONAL STUDY EVALUATING THE ADDITION OF INT-747 TO URSODEOXYCHOLIC ACIDMason, A. / Luketic, V. / Lindor, K. / Hirschfield, G. / Gordon, S. / Mayo, M. / Kowdley, K. / Pares, A. / Trauner, M. / Castelloe, E. et al. | 2010
- S4
-
8 EARLY PREDICTION OF SUSTAINED RESPONSE TO PEGINTERFERON ALFA-2A IN HBEAG-NEGATIVE PATIENTS: THE ROLE OF ON-TREATMENT HBSAG AND HBV DNA LEVELSRijckborst, V. / Hansen, B. E. / Cakaloglu, Y. / Ferenci, P. / Tabak, F. / Akdogan, M. / Simon, K. / Akarca, U. S. / Flisiak, R. / Verhey, E. et al. | 2010
- S5
-
11 T CELL RECEPTOR-LIKE ANTIBODIES TARGETING HBV INFECTED HEPATOCYTES: A NEW TOOL FOR DRUG DELIVERY AND PATHOGENIC STUDIESSastry, K. S. / Too, C. T. / Kaur, K. / Low, L. / Gehring, A. / MacAry, P. / Bertoletti, A. et al. | 2010
- S6
-
13 TELBIVUDINE (LDT) PLUS PEG-INTERFERON (PEGIFN) IN HBEAG-POSITIVE CHRONIC HEPATITIS B - VERY POTENT ANTIVIRAL EFFICACY BUT RISK OF PERIPHERAL NEUROPATHY (PN)Marcellin, P. / Avila, C. / Wursthorn, K. / Chuang, W. L. / Lau, G. K. / Peng, C. Y. / Gane, E. J. / Fainboim, H. / Manns, M. P. / Naoumov, N. V. et al. | 2010
- S8
-
18 BETA-2-ADRENERGIC RECEPTOR FUNCTION IS DIFFERENT ACCORDING TO PROPRANOLOL RESPONSE AND POLYMORPHISMS PRESENCE IN PORTAL HYPERTENSION CIRRHOTIC PATIENTSPeiro, A. M. / Gomez-Escolar, L. / Zapater, P. / Gimenez, P. / Palazon, J. M. et al. | 2010
- S9
-
21 FUNCTIONAL RELEVANT TELOMERASE MUTATIONS ASSOCIATE WITH CIRRHOSIS FORMATION IN PATIENTS WITH CHRONIC LIVER DISEASEHartmann, D. / Srivastava, U. / Thaler, M. / Kleinhans, K. / Kratzer, R. / Bauer, K. / Katz, S. F. / Begus-Nahrmann, Y. / von Figura, G. / Lechel, A. et al. | 2010
- S10
-
23 PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR HEPATITIS C RECURRENCE POST ORTHOTOPIC LIVER TRANSPLANTATION (OLT): FINAL RESULTS FROM THE PROTECT STUDYGordon, F. D. / Brown, R. S. / Kwo, P. / Ghalib, R. J. / Crippin, J. / Vargas, H. / Brown, K. / Schiano, T. / Yu, X. / Chaudhri, E. et al. | 2010
- S12
-
28 EMTRICITABINE/TENOFOVIR DF COMBINATION +/- HBIG POST-ORTHOTOPIC LIVER TRANSPLANTATION TO PREVENT HEPATITIS B RECURRENCE IN PATIENTS WITH NORMAL TO MODERATE RENAL IMPAIRMENT: INTERIM RESULTSTeperman, L. / Spivey, J. / Poordad, F. / Schiano, T. / Bzowej, N. / Pungpapong, S. / Martin, P. / Coombs, D. / Hirsch, K. R. / Anderson, J. et al. | 2010
- S13
-
30 ACUTE LIVER FAILURE: CURRENT EUROPEAN PERSPECTIVEWendon, J. / Manns, M. / Alexander, G. / Aldersley, M. / Burroughs, A. / Simpson, K. / Mutimer, D. / Nevens, F. / Bernal, W. / Laterre, P. F. et al. | 2010
- S14
-
33 IDENTIFICATION AND CHARACTERIZATION OF PPI-461, A POTENT AND SELECTIVE HCV NS5A INHIBITOR WITH ACTIVITY AGAINST ALL HCV GENOTYPESColonno, R. / Peng, E. / Bencsik, M. / Huang, N. / Zhong, M. / Huq, A. / Huang, Q. / Williams, J. / Li, L. et al. | 2010
- S16
-
38 RITONAVIR BOOSTING OF LOW DOSE RG7227/ITMN-191, HCV NS3/4A PROTEASE INHIBITOR, RESULTS IN ROBUST REDUCTION IN HCV RNA AT LOWER EXPOSURES THAN PROVIDED BY UNBOOSTED REGIMENSGane, E. / Rouzier, R. / Stedman, C. / Wiercinska-Drapalo, A. / Horban, A. / Chang, L. / Zhang, Y. / Sampeur, P. / Najera, I. / Shulman, N. et al. | 2010
- S18
-
42 SORAFENIB AND LIVER REGENERATIONHora, C. / Romanque, P. / Ledermann, M. / Wilhelm, S. / Dufour, J. F. et al. | 2010
- S20
-
47 METABOLIC REPROGRAMMING OF LIPID METABOLISM BY THE SIDE-CHAIN MODIFIED BILE ACID, 24-NORURSODEOXYCHOLIC ACID, RESTORES INFLAMMATION-DRIVEN LIVER INJURY AND ABERRANT PROLIFERATION IN ABCB4-/- MICEMoustafa, T. / Fickert, P. / Magnes, C. / Frank, S. / Kratky, D. / Sinner, F. / Gumhold, J. / Silbert, D. / Halsegger, S. / Trauner, M. et al. | 2010
- S24
-
52 INCREASED MORTALITY ON THE LIVER TRANSPLANT WAITING LIST IN FEMALES UNDER THE MELD ALLOCATION SYSTEM: UTILITY OF REVISED MELD INCORPORATING ESTIMATED GLOMERULAR FILTRATION RATEMyers, R. P. / Shaheen, A. A. / Aspinall, A. I. / Quinn, R. R. / Burak, K. W. et al. | 2010
- S25
-
54 COMPLETELY INDIVIDUALIZED TREATMENT DURATIONS (24, 30, 36, 42, 48, 60 OR 72 WEEKS) WITH PEGINTERFERON-ALFA-2B AND RIBAVIRIN IN HCV GENOTYPE 1-INFECTED PATIENTS (INDIV-2 STUDY)Sarrazin, C. / Schwendy, S. / Moller, B. / Dikopoulos, N. / Buggisch, P. / Encke, J. / Teuber, G. / Goeser, T. / Thimme, R. / Klinker, H. et al. | 2010
- S30
-
65 CLINICAL, BIOCHEMICAL AND GENETIC FEATURES IN TRANSALDOLASE DEFICIENCY, A NEW DISORDER IN PEDIATRIC HEPATOLOGYWamelink, M. M. / Valayannopoulos, V. / Struys, E. A. / Salomons, G. S. / Jakobs, C. et al. | 2010
- S31
-
68 IMPACT OF GENDER ON THE CLINICAL PRESENTATION OF WILSON DISEASEFerenci, P. / Merle, U. / Czlonkowska, A. / Bruha, R. / Houwen, R. / Szalay, F. / Vogel, W. / Stremmel, W. et al. | 2010
- S32
-
70 CYLD: A KEY REGULATOR OF HEPATOCELLULAR APOPTOSIS, PROLIFERATION AND CARCINOGENESISUrbanik, T. / Heine, S. / Worns, M. / Hovelmeyer, N. / Boger, R. J. / Maass, T. / Massoumi, R. / Fassler, R. / Schuchmann, M. / Galle, P. R. et al. | 2010
- S33
-
73 TAK1 SUPPRESSES A NEMO-DEPENDENT, BUT NF-KAPPAB-INDEPENDENT PATHWAY TO LIVER CANCERBettermann, K. / Vucur, M. / Haybaeck, J. / Liedtke, C. / Tacke, F. / Heikenwalder, M. / Trautwein, C. / Luedde, T. et al. | 2010
- S34
-
75 KERATIN 19 EXPRESSION IN HEPATOCELLULAR CARCINOMA IS CORRELATED WITH POSTOPERATIVE TUMOUR RECURRENCE AND METASTASIS MARKERSSpee, B. / Govaere, O. / Durnez, A. / Borght, S. V. / Verslype, C. / Aerts, R. / Topal, B. / Pirenne, J. / Nevens, F. / Desmet, V. J. et al. | 2010
- S35
-
78 VALIDATION OF CONTROLLED ATTENUATION PARAMETER (CAP) AS A NON-INVASIVE MARKER OF STEATOSIS IN 228 PATIENTS WITH CHRONIC LIVER DISEASE FROM VARIOUS CAUSESBeaugrand, M. / de Ledinghen, V. / Douvin, C. / Marcellin, P. / Poupon, R. / Fournier, C. / Sandrin, L. / Miette, V. / Sasso, M. et al. | 2010
- S36
-
80 ROLE FOR PPAR g IN HEPATIC STEATOSIS AS DETERMINED BY HEPATOCYTE AND KUPFFER CELL-SPECIFIC CONDITIONAL KNOCKOUTS USING CRE RECOMBINASEMoran-Salvador, E. / Lopez-Parra, M. / Titos, E. / Martinez-Clemente, M. / Gonzalez-Periz, A. / Horrillo, R. / Lopez-Vicario, C. / Barak, Y. / Arroyo, V. / Claria, J. et al. | 2010
- S39
-
87 A NOVEL STRATEGY TO OVERCOME IMMUNE TOLERANCE DURING PERSISTENT HEPATITIS B VIRUS INFECTIONMichel, M. L. / Mancini-Bourgine, M. / Zhu, R. / Zhang, X. M. / Cumont, M. C. / Lone, Y. C. / Deng, Q. et al. | 2010
- S43
-
95 CAVEOLIN-1 REGULATES MITOCHONRIAL CHOLESTEROL AND HEPATOCELLULAR SUSCEPTIBILITY TO TNF/FASMari, M. / Bosch, M. / Fernandez, A. / Kassan, A. / Colell, A. / Enrich, C. / Garcia-Ruiz, C. / Pol, A. / Fernandez-Checa, J. C. et al. | 2010
- S44
-
97 THE BENEFICIAL EFFECT OF ANGIOTENSIN-BLOCKING AGENT ON LIVER FIBROSIS IN PATIENTS WITH ALCOHOLIC LIVER DISEASE: A RANDOMIZED CONTROLLED TRIALKim, M. Y. / Cho, M. Y. / Baik, S. K. / Won, C. S. / Byun, J. W. / Park, H. J. / Choi, H. J. / Chun, H. K. / Park, S. Y. / Kwon, Y. H. et al. | 2010
- S46
-
102 PIVOTAL EFFECTS OF TOLL-LIKE RECEPTOR-9 ACTIVATION IN HEPATIC FIBROSISAmer, J. / Axelrod, J. H. / Khvalevsky, E. / Doron, S. / Abu Tair, L. / Nechemia, Y. / Galun, E. / Safadi, R. et al. | 2010
- S48
-
107 HEPATITIS B VIRUS (HBV) BYPASSES CLASSICAL ENDOCYTIC PATHWAYS TO INFECT PRIMARY HEPATOCYTES IN VITROKott, N. / Konig, A. / Glebe, D. et al. | 2010
- S49
-
110 MODULATION OF HBV REPLICATION AND CELLULAR GENE EXPRESSION BY MICRORNA-1Zhang, X. / Zhang, E. / Meng, Z. / Ma, Z. / Schlaak, J. / Lu, M. et al. | 2010
- S50
-
113 MONOCLONAL ANTI-CLAUDIN 1 ANTIBODIES FOR PREVENTION OF HEPATITIS C VIRUS RE-INFECTION IN LIVER TRANSPLANTATIONFofana, I. / Krieger, S. / Grunert, F. / Glauben, S. / Soulier, E. / Xiao, F. / Royer, C. / Fafi-Kremer, S. / Schuster, C. / Thompson, J. et al. | 2010
- S51
-
115 PRE TRANSPLANT AFP LEVEL IS A SIMPLE AND USEFUL TEST FOR A CONTROLLED EXPANSION OF MILAN CRITERIA IN LIVER TRANSPLANT CANDIDATES FOR HEPATOCELLULAR CARCINOMADuvoux, C. / Decaens, T. / Pessione, F. / Badran, H. / Compagnon, P. / Piardi, T. / Muscari, F. / Francoz, C. / Salame, E. / Dharancy, S. et al. | 2010
- S52
-
118 ADVANCED CYTOLOGY FOR THE DIAGNOSIS OF MALIGNANT BILE DUCT STRICTURES IN PATIENTS WITH JAUNDICE: A TWO-STEP APPROACHSartori, M. / Orsello, M. / Montino, F. / Ballare, M. / Pagliarulo, M. / Boldorini, R. / Paganotti, A. / Carmagnola, S. / Andorno, S. / Del Piano, M. et al. | 2010
- S56
-
126 PREDICTIVE ROLE OF IL28B C/C GENOTYPE ON SVR AND RVR IN PATIENTS WITH GENOTYPE 2/3 CHRONIC INFECTIONMangia, A. / Tompson, A. / Santoro, R. / Piazzolla, V. / Mottola, L. / Shianna, K. / Petruzzellis, D. / Goldstein, D. / McHutchison, J. et al. | 2010
- S59
-
131 HEPATIC STELLATE CELL ACTIVATION: AN IMPORTANT CONTRIBUTOR TO PERSISTENT HEPATIC RESISTANCE IN SMALL-FOR-SIZE LIVERS AFTER EXTENDED PARTIAL HEPATECTOMY IN THE RATFan, Y. D. / Vanheule, E. / Meester, D. / Van Huysse, J. / Olievier, K. / Praet, M. / Colle, I. / de Hemptinne, B. et al. | 2010
- S62
-
139 LIVER REGENERATION AND SURVIVAL AFTER SUBTOTAL HEPATECTOMY IN A FATTY LIVER MODEL IS IMPROVED BY VEGFGu, Y. / Sowa, J. P. / Paul, A. / Schlaak, J. et al. | 2010
- S63
-
142 INTRA- AND EXTRAHEPATIC CONSEQUENCES OF THE SPLIT LIVER PROCEDURE; AN ADJUVANT PRECONDITIONING PROTOCOL TO IMPROVE LIVER HARVESTvon Heesen, M. / Menger, M. / Schilling, M. / Moussavian, M. R. et al. | 2010
- S65
-
147 INHIBITORY CONTROL TASK: FOCUS ON THE DETECTION OF MINIMAL HEPATIC ENCEPHALOPATHYAmodio, P. / Ridola, L. / Schiff, S. / Montagnese, S. / Pasquale, C. / Nardelli, S. / Pentassuglio, I. / Trezza, M. / Marzano, C. / Flaiban, C. et al. | 2010
- S66
-
150 SEVERITY OF CHRONIC COGNITIVE IMPAIRMENT IN CIRRHOSIS INCREASES WITH NUMBER OF EPISODES OF OVERT HEPATIC ENCEPHALOPATHYBajaj, J. / Schubert, C. / Sanyal, A. J. / Bell, D. / Pisney, L. / Heuman, D. M. et al. | 2010
- S67
-
152 TRANSDERMAL RIVASTIGMINE FOR TREATMENT OF ENCEPHALOPATHY IN LIVER CIRRHOSIS - A RANDOMIZED PLACEBO CONTROLLED TRIAL (TREC TRIAL)Basu, P. / Shah, N. J. / Krishnaswamy, N. / Hampole, H. / Pacana, T. / Rayapudi, K. / Brown, R. et al. | 2010
- S68
-
155 IMPACT OF THE USE OF ALBUMIN FOR COMPLICATIONS OF CIRRHOSIS ON THE GLOBAL ALBUMIN CONSUMPTION AND PHARMACEUTICAL COSTS IN AN ACADEMIC HOSPITALMirici-Cappa, F. / Caraceni, P. / Gelonesi, E. / Bevilacqua, V. / Benazzi, B. / Domenicali, M. / Trevisani, F. / Puggioli, C. / Bernardi, M. et al. | 2010
- S69
-
158 MORTALITY AFTER SURGERY IN PATIENTS WITH LIVER CIRRHOSIS: COMPARISON BETWEEN CTP, MELD AND MELDNA SCORECho, H. C. / Sinn, D. H. / Jung, H. Y. / Choi, M. S. / Koh, K. C. / Paik, S. W. / Yoo, B. C. / Kim, S. W. / Lee, J. H. et al. | 2010
- S70
-
161 THDP-17 INHIBITS THE GLUTAMINASE ACTIVITY IN CACO-2 CELL CULTURESHerrero, M. M. / del Campo, J. A. / Carbonero, P. / Jover, M. / Perez, J. V. / Guerra, F. I. / Perinnan, I. / Bautista, J. D. / Gomez, M. R. et al. | 2010
- S71
-
163 ASSESSMENT OF ADRENOCORTICAL RESERVE IN STABLE PATIENTS WITH CIRRHOSISFede, G. / Spadaro, L. / Tomaselli, T. / Privitera, G. / OBeirne, J. / Garcovich, M. / Tsochatzis, E. / Burroughs, A. K. / Purrello, F. et al. | 2010
- S72
-
166 CONTRAST-ENHANCED CARDIAC MRI REVEALS PATHOLOGICAL MYOCARDIAL ALTERATIONS - CIRRHOTIC CARDIOMYOPATHY LINKED TO PORTAL HYPERTENSIONGotthardt, D. / Weiss, K. H. / Zahn, A. / Stremmel, W. / Sauer, P. / Lossnitzer, D. et al. | 2010
- S73
-
169 CARVEDILOL OR PROPRANOLOL IN PORTAL HYPERTENSION? A RANDOMIZED CLINICAL TRIALHobolth, L. / Moller, S. / Gronbaek, H. / Keiding, S. / Bendtsen, F. / Feldager, E. et al. | 2010
- S75
-
174 VON WILLEBRAND FACTOR LEVELS CORRELATE WITH THE SEVERITY OF PORTAL HYPERTENSION AND INDEPENDENTLY PREDICT THE CLINICAL OUTCOME OF CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSIONLa Mura, V. / Reverter, J. C. / Flores-Arroyo, A. / Hernandez-Guerra, M. / Abraldes, J. G. / Garcia-Pagan, J. C. et al. | 2010
- S76
-
177 SPLANCHNIC DETERMINANTS OF THE HYPERDYNAMIC CIRCULATION AND CENTRAL HYPOVOLAEMIA IN CIRRHOSISHobolth, L. / Christensen, E. / Dumcke, C. W. / Bendtsen, F. / Moeller, S. et al. | 2010
- S77
-
179 A PROSPECTIVE COHORT STUDY INVESTIGATING THE NATURAL HISTORY OF ACUTE-ON-CHRONIC LIVER FAILURENevens, F. / Katoonizadeh, A. / Verslype, C. / Maleux, G. / Roskams, T. / Wilmer, A. / Laleman, W. et al. | 2010
- S78
-
182 THERAPEUTIC EFFICACY OF L-ORNITHINE-L-ASPARTATE INFUSIONS IN PATIENTS WITH CIRRHOSIS AND HEPATIC ENCEPHALOPATHYOruc, N. / Ozturk, A. / Onal, I. K. / Unal, N. G. / Akdogan, M. / Yurdaydin, C. / Karasu, Z. / Ozutemiz, O. et al. | 2010
- S81
-
189 MILD HEPATIC ENCEPHALOPATHY (HE) ASSESSED BY THE REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS (RBANS) IS HIGHLY PREVALENT IN AMBULATORY PATIENTS WITH CIRRHOSISRandolph, C. / Bajaj, J. / Sheikh, M. Y. / Vemuru, R. / Morelli, G. / Balart, L. A. / Chojkier, M. / Harris, M. S. / Bornstein, J. D. / Mullen, K. et al. | 2010
- S82
-
191 CLINICAL EFFICACY OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT CREATED WITH COVERED STENTS WITH DIFFERENT DIAMETERS: RESULTS OF A RANDOMIZED CONTROLLED TRIALRiggio, O. / Ridola, L. / Angeloni, S. / Cerini, F. / Fanelli, F. / Salvatori, F. M. / Merli, M. et al. | 2010
- S83
-
193 REPEAT MEASUREMENTS DO NOT ADD FURTHER INFORMATION TO SINGLE MEASUREMENTS IN THE PREDICTION OF OUTCOMES IN CIRRHOSISLastra, P. / Ripoll, C. / Rincon, D. / Catalina, V. / Bannares, R. et al. | 2010
- S85
-
198 RENIN-ANGIOTENSIN-ALDOSTERONE INHIBITORS FOR THE REDUCTION OF PORTAL PRESSURE: A META-ANALYSIS AND SYSTEMATIC REVIEWTandon, P. / Abraldes, J. G. / Berzigotti, A. / Garcia-Pagan, J. C. / Bosch, J. et al. | 2010
- S86
-
201 PORTOPULMONARY HYPERTENSION AND SERUM ENDOTHELIN LEVELS IN PATIENTS WITH CIRRHOSISTsiakalos, A. P. / Hatzis, G. / Moyssakis, I. / Karatzaferis, A. / Ziakas, P. D. / Tzelepis, G. E. et al. | 2010
- S88
-
206 REPRODUCIBILITY AND RELIABILITY OF THE HEPATIC VENOUS PRESSURE GRADIENT (HVPG) MEASUREMENT IN PATIENTS WITH CIRRHOSIS IS HIGHER USING THE BALLOON COMPARED TO THE STRAIGHT CATHETERZipprich, A. / Winkler, M. / Seufferlein, T. / Dollinger, M. M. et al. | 2010
- S89
-
209 FIBROSIS PROGRESSION DURING SUNITINIB THERAPY IN CIRRHOTIC PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMABiolato, M. / Basso, M. / Forgione, A. / Racco, S. / Miele, L. / Pompili, M. / Rapaccini, G. L. / Landolfi, R. / Barone, C. / Grieco, A. et al. | 2010
- S90
-
212 CONTRAST-ENHANCED US (CEUS) IN EARLY EVALUATION OF NON-SURGICAL TREATMENT OF HCC CAN CHANGE THE PATIENTS FOLLOW-UP AND SURVIVALGiangregorio, F. / Aragona, G. / Marinone, G. / Comparato, G. / Fanigliulo, L. / Di Stasi, M. / Sbolli, G. / Tansini, P. / Fornari, F. et al. | 2010
- S94
-
223 SURVIVAL COMPARISON BETWEEN SURGICAL RESECTION AND RADIOFREQUENCY ABLATION IN HEPATOCELLULAR CARCINOMA PATIENTS WITH BCLC (VERY) EARLY STAGELu, S. N. / Wang, J. H. / Chen, C. L. et al. | 2010
- S95
-
226 EFFICACY AND SAFETY OF SORAFENIB AT LONG TERM IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): NEED TO SCREEN FOR CARDIOVASCULAR EVENTS AFTER LONG TERM ADMINISTRATIONReig, M. / Forner, A. / de Lope, C. R. / Rimola, J. / Tremosini, S. / Mestres, C. / Ayuso, C. / Llovet, J. M. / Bruix, J. et al. | 2010
- S97
-
230 YOUNG HEPATOCELLULAR CARCINOMA PATIENTS HAD BETTER OVERALL SURVIVAL AND LOWER INCIDENCE OF DEVELOPING LATE RECURRENCE AFTER RESECTION SURGERYSu, C. W. / Chau, G. Y. / Lei, H. J. / Wu, J. C. / Lee, S. D. / Lui, W. Y. et al. | 2010
- S98
-
233 MANAGEMENT OF HEPATOCELLULAR ADENOMA DURING PREGNANCYvan Aalten, S. M. / Noels, J. E. / van der Windt, D. J. / Kok, N. F. / de Man, R. A. / Terkivatan, T. / Ijzermans, J. N. et al. | 2010
- S99
-
236 TWELVE-WEEK COURSE OF PIFN-a-2A/RIBAVIRIN IS AN OPTIMIZED REGIMEN FOR TREATMENT OF HCV GENOTYPE 2 BUT NOT GENOTYPE 3 NON-CIRRHOTIC PATIENTS WITH RVRAdinolfi, L. E. / Zampino, R. / Guerrera, B. / Restivo, L. / Rinaldi, L. / Ciervo, A. / Scialdone, V. R. / Ferrara, M. / Ruggiero, G. et al. | 2010
- S101
-
240 SUSTAINED VIROLOGICAL RESPONSE IMPROVES SURVIVAL IN HCV-RELATED LIVER CIRROSIS WITH PORTAL HYPERTENSIONAnnicchiarico, B. E. / Siciliano, M. / Iacobellis, A. / Avolio, A. W. / Caracciolo, G. / Andriulli, A. / Bombardieri, G. et al. | 2010
- S103
-
245 HIGH VIRAL RESPONSE IN A MULTIDISCIPLINARY NETWORK NOT ORGANIZED UNDER ONE ROOF FOR ANTIVIRAL MANAGEMENT OF CHRONIC HEPATITIS C VIRAL PATIENTS INFECTED AFTER SUBSTANCE USEBourgeois, S. / Schrooten, W. / Robaeys, G. et al. | 2010
- S105
-
250 HEPATITIS C TREATMENT IN PATIENTS WITH GENOTYPE 2/3: 16 VS. 24 WEEKS; ANALYSIS OF OUTCOME, HRQOL, DIRECT AND INDIRECT COSTSDal Bianco, T. / Grasso, A. / Carlotto, A. / Malfatti, F. / Miotti, A. M. / Giordani, M. T. / Tramarin, A. / Fabris, P. et al. | 2010
- S106
-
253 ASSOCIATION OF HOST PHARMACODYNAMIC EFFECTS AND VIROLOGIC RESPONSE TO PEGINTERFERON ALFA-2A/RIBAVIRIN IN PATIENTS WITH CHRONIC HEPATITIS CChung, R. T. / Di Bisceglie, A. / Poordad, F. F. / Hassanein, T. / Zhou, X. / Lentz, E. / Prabhakar, A. / Hamzeh, F. M. et al. | 2010
- S108
-
258 ASSOCIATION OF SERUM INTERFERON-GAMMA INDUCIBLE PROTEIN 10 (IP-10) LEVELS WITH VIROLOGICAL RESPONSE TO PEGYLATED INTERFERON ALFA-2B PLUS RIBAVIRIN THERAPY FOR HCV GENOTYPE 1 INFECTIONFukuda, M. / Yatsuhashi, H. / Takahara, I. / Murata, T. / Hashimoto, S. / Nishikawa, A. / Bae, S. K. / Motoyoshi, Y. / Nagaoka, S. / Yanagi, K. et al. | 2010
- S109
-
260 SUCCESSFUL THERAPY WITH PEGYLATED INTERFERON ALFA-2A AND RIBAVIRIN CAUSES A SUSTAINED DECREASE IN PORTAL PRESSURE IN PATIENTS WITH CHRONIC HEPATITIS C-RELATED CIRRHOSISGarcia-Retortillo, M. / Rincon, D. / Albillos, A. / Colmenero, J. / Bataller, R. / Calleja, J. L. / Bannares, R. / Abraldes, J. G. / Bosch, J. / Sanchez-Tapias, J. M. et al. | 2010
- S110
-
263 RAPID VIROLOGICAL RESPONSE IS A PREDICTOR OF SUSTAINED VIROLOGICAL RESPONSE IN CHRONIC HEP C G3 PATIENTS TREATED WITH PEGASYS AND RBVAdeeb, U. / Khattak, F. / Gill, M. L. et al. | 2010
- S112
-
268 RELATIONSHIP OF SERUM IP-10 LEVELS WHICH REFLECTS HEPATIC INTERFERON STIMULATING GENE INDUCTION AND ANTIVIRAL EFFECT OF PEG/RBV COMBINATION THERAPY IN PATIENT WITH CHRONIC HEPATITIS CKarino, Y. / Toyota, J. / Arakawa, T. / Kuwata, Y. / Akaike, J. / Ozeki, I. / Sato, T. / Ohmura, T. et al. | 2010
- S114
-
273 SHORT TERM SAFETY, TOLERABILITY, PHARMACOKINETICS AND PRELIMINARY ACTIVITY OF GS-9450, A SELECTIVE CASPASE INHIBITOR, IN PATIENTS WITH CHRONIC HCV INFECTIONManns, M. P. / Lawitz, E. / Hoepelman, A. I. / Choi, H. J. / Lee, J. Y. / Cornpropst, M. / Liang, W. / King, B. / Hirsch, K. R. / Oldach, D. et al. | 2010
- S117
-
280 RETREATMENT WITH PEG-IFN ALPHA-2A PLUS RIBAVIRIN FOR 48 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 2 AND 3 RELAPSERS TO A PREVIOUS ANTIVIRAL TREATMENTMinola, E. / Baldo, V. / Baldovin, T. / Floreani, A. et al. | 2010
- S118
-
283 HCV PROTEASE INHIBITOR RESTORES INSULIN SENSITIVITY IN GENOTYPE 1 CHRONIC HEPATITIS C PATIENTSMoucari, R. / Forestier, N. / Larrey, D. / Guyader, D. / Couzigou, P. / Benhamou, Y. / Voitot, H. / Vidaud, M. / Seiwert, S. / Bradford, B. et al. | 2010
- S119
-
286 EXPOSURE-RESPONSE RELATIONSHIP OF FILIBUVIR IN HCV INFECTED PATIENTS: APPLICATION TO DOSE SELECTION FOR COMBINATION THERAPYNeelakantan, S. / Purohit, V. S. / OGorman, M. / Hammond, J. / Tensfeldt, T. G. et al. | 2010
- S120
-
288 INFRADURE: SUSTAINED DELIVERY OF INTERFERON-ALPHA (IFNa) IN SCID MICE BY IMPLANTED IFNA SECRETING DERMAL BIOPUMPSStern, B. / Shoshani, E. / Pearlman, A. / Ng, P. / Meari, R. / Goltzmann, H. / Rimler, A. / Okun, A. / Bookay, H. / Gibly, T. et al. | 2010
- S121
-
290 EARLY VIROLOGICAL RESPONSE PROFILES WITH TELAPREVIR (T) IN COMBINATION WITH PEGINTERFERON-ALFA-2A (P) AND RIBAVIRIN (R) IN GENOTYPE 1 HCV TREATMENT-NAIVE AND TREATMENT-EXPERIENCED PATIENTS ARE SIMILARPoordad, F. / McHutchison, J. G. / Shiffman, M. L. / Berg, T. / Muir, A. J. / Manns, M. P. / Di Bisceglie, A. M. / Terrault, N. / Picchio, G. / Kwong, A. et al. | 2010
- S123
-
295 POPULATION PHARMACOKINETICS AND EXPOSURE-RESPONSE OF ALBINTERFERON ALFA-2BRiggs, M. / Bergsma, T. / Rogers, J. / Gastonguay, M. / Subramanian, G. / Chen, C. / Devalaraja, M. / Corey, A. et al. | 2010
- S125
-
299 BASELINE CHARACTERISTICS ASSOCIATED WITH PRESCRIPTION OF RIBAVIRIN >800 MG/DAY AMONG G2/3 PATIENTS PRESCRIBED PEGINTERFERON ALFA-2A (40KD) FROM REAL-WORLD PATIENT COHORTS: INTERIM RESULTS FROM PROPHESYSShiffman, M. L. / Ferenci, P. / Hassanein, T. / Curescu, M. / Coppola, C. / Pruthi, J. / Aires, R. / Lengyel, G. / Pol, S. / Nelson, D. et al. | 2010
- S127
-
304 METABOLIC SYNDROME (MS) IS A NEGATIVE PREDICTOR OF TREATMENT OUTCOME IN PATIENTS WITH CHRONIC HEPATITIS C: RESULTS FROM THE IDEAL STUDYSulkowski, M. S. / King, J. W. / Harrison, S. A. / Rossaro, L. / Hu, K. Q. / Lawitz, E. J. / Schiffman, M. L. / Muir, A. J. / Galler, G. W. / McCone, J. et al. | 2010
- S128
-
306 RELATION OF INSULIN RESISTANCE AND HEPATIC STEATOSIS WITH ADVANCED HEPATIC FIBROSIS IN PATIENTS WITH GENOTYPE 1 OR 2/3 CHRONIC HEPATITIS CThompson, A. / Grigorescu, M. / Flisiak, R. / Horban, A. / Buti, M. / Rehak, V. / Han, K. / Safadi, R. / Cho, M. / Torbenson, M. et al. | 2010
- S131
-
313 DYNAMIC FLUCTUATION OF VIROLOGICAL MARKERS DURING THE NATURAL COURSE OF HEPATITIS DELTASerrano, B. C. / Heidrich, B. / Jaroszewicz, J. / Bremer, B. / Deterding, K. / Mederacke, I. / Raupach, R. / Cornberg, M. / Manns, M. P. / Wedemeyer, H. et al. | 2010
- S132
-
316 THE PREVALENCE OF HEPATITIS E VIRUS (HEV) IN 8 SPECIES OF ANIMALS IN BEIJING SUBURBS: EVIDENCE OF ZOONOTIC TRANSMISSION BETWEEN HUMAN AND SWINEGeng, J. / Wang, L. / Zhuang, H. / Wang, X. et al. | 2010
- S135
-
323 MOLECULAR EPIDEMIOLOGY AND SUBTYPING OF HEPATITIS E VIRUS (HEV) STRAINS CIRCULATING IN NORTH INDIAPujhari, S. K. / Ratho, R. K. / Kumar, S. / Chawala, Y. / Chakarborti, A. et al. | 2010
- S136
-
325 HEV INFECTION FOLLOWS DC-SPECIFIC INTERCELLULAR ADHESION MOLECULE 3-GRABBING NON INTEGRIN (DCSIGN) RATHER THAN TOLL LIKE RECEPTOR (TLR) DEPENDANT PATHWAY FOR VIRAL RECOGNITIONSukriti, S. / Trehanpati, N. / Dongre, K. / Patra, S. / Sarin, S. et al. | 2010
- S137
-
327 IRON STORES, LIVER TRANSAMINASE LEVELS AND METABOLIC RISK IN HEALTHY TEENAGERSAigner, E. / Hinz, C. / Steiner, K. / Patsch, W. / Datz, C. et al. | 2010
- S138
-
330 PREVALENCE AND RISK FACTORS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN RUSSIAN FEDERATIONIvashkin, V. / Drapkina, O. / Ashikhmin, Y. et al. | 2010
- S139
-
333 POLYUNSATURATED FATTY ACID COMPOSITION IN ERYTHROCYTE LIPID MEMBRANES IN NASH: UNEXPECTED HETEROGENEITY IN THE N6-N3 RATIOCaldwell, S. / Argo, C. / Al-Osaimi, A. / Shah, N. / Lothamer, H. / Harmon, C. / Rodriguez, J. et al. | 2010
- S140
-
336 HYPERHOMOCYSTEINEMIA AND C677T METHYLENETETRAHIDROFOLATE REDUCTASE GENE POLYMORPHISMS IN SPANISH PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASEVega, J. A. / Carreras, M. P. / Fernandez-Miranda, C. / Lopez-Alonso, G. / Ayala, R. / Arribas, C. / Castellano, G. et al. | 2010
- S142
-
341 PREVALENCE OF TRANSAMINASE ABNORMALITIES IN GENERAL POPULATION IN XXI CENTURY: THE BAGNACAVALLO STUDYGiacomoni, P. / Foschi, F. G. / Domenicali, M. / Savini, S. / Dazzani, F. / DallAglio, A. C. / Saini, G. / Re, G. / Casetti, T. / Andreone, P. et al. | 2010
- S143
-
344 ELEVATED LEVELS OF FETUIN A IN NONALCOHOLIC FATTY LIVER DISEASEHaukeland, J. W. / Konopski, Z. / Aasheim, E. / Johansen, O. E. / Loberg, E. M. / Haaland, T. / Gladhaug, I. / Dahl, T. / Yndestad, A. / Aukrust, P. et al. | 2010
- S145
-
349 NON-ALCOHOLIC FATTY LIVER DISEASE AND CORONARY ARTERY CALCIFICATION SCORE BY MULTI-DETECTOR COMPUTED TOMOGRAPHY; CROSS-SECTIONAL CASE-CONTROL STUDY FROM HEALTHCARE CENTERS NETWORKKim, D. / Park, E. H. / Kim, W. / Choi, S. Y. / Kim, Y. J. / Yoon, J. H. / Cho, S. H. / Lee, H. S. et al. | 2010
- S146
-
352 THIAZOLIDINEDIONES (TZDS) FOR NONALCOHOLIC STEATOHEPATITIS (NASH). A META-ANALYSISTriantos, C. / Koukias, N. / Tsamandas, A. / Nikolopoulou, V. / Burroughs, A. K. et al. | 2010
- S147
-
355 IS OIL RED-O AND DIGITAL IMAGE ANALYSIS THE GOLD STANDARD FOR QUANTIFYING STEATOSIS IN THE LIVER?Levene, A. P. / Kudo, H. / Thursz, M. R. / Anstee, Q. M. / Goldin, R. D. et al. | 2010
- S149
-
360 ASSOCIATION OF A NON-SYNONYMOUS ABCA1 GENE VARIANT WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)Canizales-Quinteros, S. / Villamil-Ramirez, H. / Sanchez-Munoz, F. / Flores-Dorantes, T. / Villarreal-Molina, T. / Dominguez-Lopez, A. / Uribe, M. / Mendez-Sanchez, N. et al. | 2010
- S150
-
363 ASSOCIATION BETWEEN EXCESSIVE SOFT DRINK CONSUMPTION, NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD), AND CORONARY ARTERY DISEASENassar, F. / Djibre, A. / Marmor, A. / Assy, N. et al. | 2010
- S151
-
366 THE IMPACT AND THE PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE ON CHRONIC HEPATITIS BPirvulescu, I. / Gheorghe, L. / Suciu, S. / Gheorghe, C. / Diculescu, M. et al. | 2010
- S152
-
369 A 3-MONTHS INTENSIVE LIFESTYLE INTERVENTION PROGRAM IMPROVED INSULIN RESISTANCE AND REDUCED THE AMOUNT OF STEATOSIS IN PATIENTS WITH NAFLDScaglioni, F. / Marino, M. / Malavolti, M. / Battistini, N. C. / Bellentani, S. et al. | 2010
- S155
-
377 BETA-GLOBIN MUTATIONS ARE ASSOCIATED WITH PARENCHYMAL SIDEROSIS AND FIBROSIS SEVERITY IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASEValenti, L. / Canavesi, E. / Galmozzi, E. / Dongiovanni, P. / Rametta, R. / Maggioni, P. / Fracanzani, A. L. / Fargion, S. et al. | 2010
- S156
-
380 LYMPHOCYTES APOPTOSIS IN NASH PATIENTS AND THE EFFECTS OF URSODEOXYCHOLIC ACIDVirstyuk, N. / Neyko, E. / Neyko, V. / Senyutovych, N. et al. | 2010
- S158
-
385 CONTROLLED ATTENUATION PARAMETER: A NOVEL FIBROSCAN-BASED TOOL TO DETECT AND QUANTIFY STEATOSIS. PRELIMINARY STUDY IN PATIENT WITH ALCOHOLOC AND NON ALCOHOLIC FATTY LIVER DISEASEBeaugrand, M. / Ziol, M. / de Ledinghen, V. / Douvin, C. / Fournier, C. / Sandrin, L. / Miette, V. / Sasso, M. et al. | 2010
- S159
-
388 SPLEEN STIFFNESS CORRELATES WITH PORTAL HYPERTENSION AND INCREASES THE ACCURACY OF DETECTION OF ESOPHAGEAL VARICES IN HCV CIRRHOSISCalvaruso, V. / Di Marco, V. / Bronte, F. / Licata, G. / Simone, F. / Butera, G. / Pecoraro, G. / Cabibbi, D. / Alessi, N. / Camma, C. et al. | 2010
- S160
-
391 ABSENCE OF INFLUENCE OF METABOLIC FACTORS ON DIAGNOSTIC PERFORMANCE OF LIVER STIFFNESS MEASUREMENT IN CHRONIC HEPATITIS B AND CCardoso, A. C. / Carvalho-Filho, R. J. / Stern, C. / Dipumpo, A. / Giuily, N. / Ripault, M. P. / Asselah, T. / Castelnau, C. / Boyer, N. / Figueiredo-Mendes, C. G. et al. | 2010
- S161
-
393 PERFORMANCE OF TRANSIENT ELASTOGRAPHY AND NON INVASIVE MARKERS OF LIVER FIBROSIS IN PRIMARY BILIARY CIRRHOSISCazzagon, N. / Chemello, L. / Martines, D. / Cavalletto, L. / Baldo, V. / Floreani, A. et al. | 2010
- S162
-
396 ASSESSMENT OF LIVER STIFFNESS (LS) IN THE RELAPSE OF ALCOHOLIC LIVER DISEASE (RALD) AFTER LIVER TRANSPLANTATION (LT)Cannesson, A. / Aftisse, H. / Boleslawski, E. / Canva, V. / Declerck, N. / Mathurin, P. / Pruvot, F. R. / Dharancy, S. et al. | 2010
- S163
-
399 ELASTOGRAPHY-BASED ASSOCIATION STUDY OF THE FUNCTIONAL FAS PROMOTER POLYMORPHISM -670A>G AND THE DEVELOPMENT OF ADVANCED FIBROSIS IN A COHORT OF PATIENTS WITH CHRONIC LIVER DISEASESGrunhage, F. / Krawczyk, M. / Goebel, R. / Sauerbruch, T. / Lammert, F. et al. | 2010
- S164
-
402 A COMMON ADIPONUTRIN VARIANT REPRESENTS A GENERAL RISK FACTOR FOR HEPATIC FIBROSIS: ELASTOGRAPHY-BASED STUDY IN PATIENTS WITH CHRONIC LIVER DISEASESKrawczyk, M. / Grunhage, F. / Zimmer, V. / Lammert, F. et al. | 2010
- S165
-
404 PERFORMANCE OF ACOUSTIC RADIATION FORCE IMPULSE IMAGING IN THE NONINVASIVE ASSESSMENT OF LIVER FIBROSIS, IN COMPARISON TO UNIDIMENSIONAL TRANSIENT ELASTOGRAPHYLupsor, M. / Badea, R. / Stefanescu, H. / Serban, A. / Sparchez, Z. / Branda, H. / Maniu, A. et al. | 2010
- S166
-
407 PROSPECTIVE RISK ASSESSMENT FOR HEPATOCELLULAR CARCINOMA RECURRENCE BY TRANSIENT ELASTOGRAPHY AFTER CURATIVE RADIOFREQUENCY ABLATIONMasuzaki, R. / Tateishi, R. / Shiina, S. / Yoshida, H. / Nakagawa, H. / Arano, T. / Uchino, K. / Enooku, K. / Goto, E. / Kondo, Y. et al. | 2010
- S169
-
415 NONINVASIVE EVALUATION OF HEPATIC FIBROSIS IN HCV-INFECTED PATIENTS USING EOB-MR IMAGINGNojiri, S. et al. | 2010
- S170
-
418 GOLD-VALIDATION OF LIVER FIBROSIS ESTIMATES, FIBROTEST (FT) AND LIVER STIFFNESS MEASUREMENT (LSM), USING SURGICAL SAMPLES AND VIRTUAL BIOPSIESPoynard, T. / Lenaour, G. / Charlotte, F. / Munteanu, M. / Vaillant, J. C. / Ngo, Y. / Ratziu, V. / Hannoun, L. / Capron, F. et al. | 2010
- S171
-
421 COMPARISON OF LIVER STIFFNESS ASSESSMENT BY FIBROSCAN AND ACOUSTIC RADIATION FORCE IMPULSE IMAGING FOR THE EVALUATION OF LIVER FIBROSIS AND CIRRHOSISSalzl, P. / Reiberger, T. / Homoncik, M. / Payer, B. / Schwengerer, B. / Peck-Radosavljevic, M. / Ferlitsch, A. et al. | 2010
- S173
-
426 WHICH ULTRASOUND BASED METHOD TO CHOSE FOR THE NON-INVASIVE EVALUATION OF LIVER FIBROSIS?Sporea, I. / Sirli, R. / Popescu, A. / Danila, M. / Nicolita, D. / Deleanu, A. et al. | 2010
- S174
-
429 ADRENAL INSUFFICIENCY IN PATIENTS WITH CIRRHOSIS AND VARICEAL BLEEDINGTriantos, C. / Marzigie, M. / Fede, G. / Michalaki, M. / Giannakopoulou, D. / Zisimopoulos, K. / Thomopoulos, K. / Makri, M. / Kyriazopoulou, V. / Jelastopulu, E. et al. | 2010
- S175
-
432 PROSPECTIVE INDEPENDENT VALIDATION AND COMPARISON OF 10 BIOMAKERS AND TRANSIENT ELASTROGRAPHY (FIBROSCAN) FOR LIVER FIBROSIS ASSESSMENT IN PATIENTS WITH CHRONIC HEPATITIS CZarski, J. P. / Sturm, N. / Guechot, J. / Paris, A. et al. | 2010
- S176
-
435 LOW NK CELL NUMBER, LOW HCV-SPECIFIC IL-10 PRODUCTION AND HIGH CD56BRIGHT CELL NUMBER PREDICT RESPONSE TO PEGYLATED-INTERFERON/RIBAVIRIN THERAPY IN CHRONIC HEPATITIS C IN CHILDRENCarey, I. / Mendes, A. / Cebecauerova, D. / Bansal, S. / Subramaniam, P. / Tizzard, S. / Mieli-Vergani, G. / Vergani, D. et al. | 2010
- S177
-
438 A REVISIT TO THE HETEROGENEITY OF HEPATIC MACROPHAGES: FUNCTIONAL AND PHENOTYPIC ASSESSMENT OF CONVENTIONAL KUPFFER CELLS VERSUS NON-KUPFFER MACROPHAGESWu, G. D. / He, Y. / Klein, A. et al. | 2010
- S179
-
443 INTRAHEPATIC EXPRESSION OF CCL17 AND CCL22 CHEMOKINES IN HEPATITIS C VIRUS INFECTED PATIENTS MAY PROMOTE THE RECRUITMENT OF T REGULATORY CELLS AND CHRONICITY OF INFECTIONRiezu-Boj, J. I. / Larrea, E. / Aldabe, R. / Guembe, L. / Galeano, E. / Echeverria, I. / Sarobe, P. / Prieto, J. / Lasarte, J. J. et al. | 2010
- S180
-
446 HCV/TLR3-DEPENDENT INNATE AND ADAPTIVE IMMUNE FUNCTIONS OF NON-PARENCHYMAL LIVER CELLS ARE CONTROLLED BY INTERLEUKIN-10 AND TRANSFORMING GROWTH FACTOR BETAJiang, M. / Wu, J. / Zhang, E. / Meng, Z. / Trippler, M. / Broering, R. / Roggendorf, M. / Gerken, G. / Lu, M. / Schlaak, J. et al. | 2010
- S181
-
449 POTENTIAL ROLE OF CD133/CD117 POSITIVE STEM CELLS IN LIVER FIBROSIS CAUSED BY SCHISTOSOMA MANSONI INFECTIONSVerhoeven, S. / Draelants, C. / Chatterjee, S. / Ponsaerts, P. / Van Marck, E. / Gehling, U. et al. | 2010
- S185
-
457 "DE NOVO" AMYLOIDOSIS IN RECIPIENTS OF DOMINO LIVER TRANSPLANTATION: CLINICAL AND HISTOLOGICAL DATABaliellas, C. / Llado, L. / Casasnovas, C. / Castellote, J. / Fabregat, J. / Ferrer, I. / Rota, R. / Torras, J. / Ramos, E. / Xiol, X. et al. | 2010
- S186
-
460 RECIPIENT MTHFR C677T POLYMORPHISM PREDICTS PRE-TRANSPLANT CIRRHOSIS PROGRESSION AND SURVIVAL AFTER LIVER TRANSPLANTATIONGinanni Corradini, S. / Burza, M. A. / Ferri, F. / Molinaro, A. / Cantafora, A. / Blotta, I. / Mordenti, M. / Mazzucconi, M. G. / Ferretti, G. / Giannelli, V. et al. | 2010
- S188
-
465 LONG TERM RESULTS OF LIVER TRANSPLANTATION FOR WILSONS DISEASE (WD): THE FRENCH EXPERIENCEGuilllaud, O. / Dumortier, J. / Durand, F. / Vanlemmens, C. / Calmus, Y. / Duvoux, C. / Kamar, N. / Lorho, R. / Wolf, P. / Bernard, P. H. et al. | 2010
- S189
-
468 ANALYSIS OF FACTORS ASSOCIATED WITH SOCS3 EXPRESSION IN HUMAN LIVER ALLOGRAFTS EARLY AFTER LIVER TRANSPLANTATIONFangazio, S. / Giarda, P. / Grossi, G. / Minisini, R. / Bitetto, D. / Occhino, G. / Burlone, M. E. / Toniutto, P. / Falleti, E. / Fabris, C. et al. | 2010
- S190
-
470 DIABETES MELLITUS (DM) REDUCES SURVIVAL AFTER LIVER TRANSPLANTATION (LT): ANALYSIS OF A MONOCENTRIC COHORTFaure, S. / Mura, T. / Bismuth, M. / Assenat, E. / Herrero, A. / Bouyabrine, H. / Yung, B. / Navarro, F. / Jaber, S. / Larrey, D. et al. | 2010
- S191
-
473 NON ADHERENCE TO MEDICAL PRESCRIPTIONS IN LIVER TRANSPLANTATION: A PROSPECTIVE LONGITUDINAL STUDYGermani, G. / Gnoato, F. / Borella, V. / Lazzaro, S. / Perissinotto, E. / Senzolo, M. / Russo, F. P. / De Martin, E. / Gambato, M. / Nadal, E. et al. | 2010
- S192
-
476 WHICH CORRELATION AMONG HISTOLOGICAL ASSESSMENT OF FIBROSIS, NON-INVASIVE MARKERS AND PORTAL HYPERTENSION IN HCV TRANSPLANTED PATIENTS?Isgro, G. / Calvaruso, V. / Manousou, P. / Luong, T. V. / Andreana, L. / Maimone, S. / Makalanda, L. / Marelli, L. / Patch, D. / Davies, N. et al. | 2010
- S193
-
479 LIVER TRANSPLANTATION FOR ALPHA-1 ANTITRYPSIN DEFICIENCY: HEPATOCELLULAR CARCINOMA IS COMMON AND DETERIORATES SURVIVALKok, K. / Porte, R. J. / Adam, R. / van den Berg, A. / Scheenstra, R. / Metselaar, H. / van Hoek, B. / van Oijen, M. G. / Drenth, J. P. et al. | 2010
- S194
-
481 CPA MEASUREMENT AT ONE YEAR BIOPSY IS HIGHLY PREDICTIVE OF FUTURE CLINICAL DECOMPENSATION IN HCV POST-TRANSPLANT PATIENTS RANDOMIZED IN TACROLIMUS MONOTHERAPY VERSUS TRIPLE THERAPY (TACROLIMUS-BASED)Manousou, P. / Samonakis, D. / Cholongitas, E. / Isgro, G. / Calvaruso, V. / Tsochatzis, E. / Patch, D. W. / OBeirne, J. / Thornburn, D. / Tsianos, E. V. et al. | 2010
- S195
-
484 IMPORTANCE OF LIVER BIOPSY TO SELECTION OF LIVING-DONOR FOR LIVER TRANSPLANTATIONKarakayali, H. / Sevmis, S. / Korkmaz, M. / Bilezikci, B. / Haberal, M. / Moray, G. et al. | 2010
- S196
-
487 PROLONGED ANTIVIRAL TREATMENT FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION IN PATIENTS WITHOUT RAPID VIROLOGICAL RESPONSE REDUCES RELAPSES AND ENHANCES SUSTAINED VIROLOGICAL RESPONSEPascasio, J. M. / Sousa, J. M. / Ferrer, M. T. / Gavilan, F. / Sayago, M. / Serrano-Diez Canedo, J. / Giraldez, A. / Barrera, L. / Alamo, J. M. / Gomez-Bravo, M. A. et al. | 2010
- S197
-
489 CLINICAL IMPACT AND BEHAVIOUR OF SERUM AUTOANTIBODIES IN ADULT LIVER TRANSPLANTATIONGranito, A. / Vannini, A. / Quarneti, C. / Muratori, P. / Muratori, L. / Pappas, G. / Piscaglia, F. / Andreone, P. / Bianchi, G. / Tame, M. R. et al. | 2010
- S198
-
492 REGULATION OF LIVER GRAFT CHOLESTEROL SYNTHESIS AND UPTAKE AFFECTS THE OUTCOME OF HUMAN LIVER TRANSPLANTATIONGinanni Corradini, S. / Siciliano, M. / Cantafora, A. / Blotta, I. / Pirazzi, C. / Parlati, L. / Molinaro, A. / Giusto, M. / Mennini, G. / Pugliese, F. et al. | 2010
- S199
-
495 ARE LIVER TRANSPLANT HIV-1 INFECTED PATIENTS AT RISK TO DEVELOP HIV-1 DRUG RESISTANCE?Teicher, E. / Desbois, D. / Dussaix, E. / Figueroa, M. / Antonini, T. / Duclos Vallee, J. C. / Samuel, D. / Vittecoq, D. et al. | 2010
- S201
-
500 THE BIOLOGICAL RESPONSE MODIFIER AM3 ATTENUATES THE LIVER AND PERIPHERAL BLOOD INFLAMMATORY IMMUNE SYSTEM ACTIVATION AND REDUCES HEPATIC FIBROSIS IN RATS WITH BILIARY CIRRHOSISAlbillos, A. / Nieto, M. / Ubeda, M. / Munnoz, L. / Fraile, B. / Reyes, E. / Lledo, L. / Blanco, I. / Salas, C. / Lario, M. et al. | 2010
- S203
-
505 A POSSIBLE ROLE OF NT-PROBNP IN THE FOLLOW-UP OF CIRRHOTIC PATIENTSDonadio, C. / Carlomagno, G. / Di Giacomo, E. / Albano, G. / Lucariello, A. et al. | 2010
- S204
-
507 ROLE OF HELICOBACTER PYLORI IN PATIENTS WITH HCV-RELATED CHRONIC HEPATITIS, CIRRHOSIS WITH OR WITHOUT HEPATOCELLULAR CARCINOMA: POSSIBLE ASSOCIATION WITH DISEASE PROGRESSIONEsmat, G. / El-Bendary, M. / Zakarya, S. / Abou Ela, M. / Zalata, K. et al. | 2010
- S205
-
510 HYPERAMMONEMIA INCREASES GABAERGIC TONE IN CEREBELLUM BUT DECREASES IT IN CORTEX OF RATS. ROLE IN COGNITIVE IMPAIRMENTCauli, O. / Agusti, A. / Felipo, V. et al. | 2010
- S206
-
513 DOUBLE-BLINDED CROSSOVER TRIAL ANALYZING THE USEFULNESS OF RIFAXIMIN IN THE TREATMENT OF MINIMAL HEPATIC ENCEPHALOPATHY (MHE): AN INTERIN ANALYSISGrande, L. / Jover, M. / Fobelo, M. / Figueruela, B. / Jimenez, M. J. / Hoyas, E. / Camacho, I. / Perez, A. / Maraver, M. / Aparcero, R. et al. | 2010
- S207
-
516 GLYCOGEN SYNTHASE KINASE 3 (GSK3) IN IMMUNE CELLS IS A MAJOR PLAYER INTLR4-MEDIATED CYTOKINE STORM IN PATIENTS WITH ADVANCED CIRRHOSISGustot, T. / Simon-Rudler, M. / Fasseu, M. / Gandoura, S. / Abdel-Razek, W. / Deviere, J. / Lebrec, D. / Moreau, R. et al. | 2010
- S208
-
519 IGF-1 REPLACEMENT THERAPY IN RATS WITH HEPATIC ENCEPHALOPATHY INDUCED BY PORTACAVAL SHUNTJover, M. / Camacho, I. / Diaz, D. / Garcia-Fernandez, M. I. / Puche, J. E. / Castilla-Cortazar, I. / Grande, L. / Rodriguez-Ortigosa, C. M. / Prieto, J. / Bautista Palomas, J. D. et al. | 2010
- S209
-
522 EXPERIMENT STUDY OF TIMP-1 SIRNA ON LIVER FIBROSIS IN RATSLang, Q. / Xu, N. / Qi, J. H. / Qian, K. L. / Shi, X. F. et al. | 2010
- S210
-
525 THE EXPRESSION OF IGFBPRP1 IN LIVER TISSUE FROM PATIENTS WITH HEPATIC CIRRHOSIS AND ITS RELATIONSHIP WITH TGF-b1/SMAD PATHWAYLiu, L. X. / Zhang, H. Y. / Liu, L. Y. et al. | 2010
- S211
-
527 IMBALANCES IN PROINFLAMMATORY CYTOKINES ARE ASSOCIATED WITH PULMONARY DYSFUNCTION AND HEPATOPULMONARY SYNDROME IN CIRRHOSISMortensen, C. / Andersen, O. / Bendtsen, F. / Moller, S. et al. | 2010
- S212
-
530 A SINGLE NUCLEOTIDE POLYMORPHISM IN THE P53 PATHWAY INTERACTS WITH HEPATIC COPPER TOXICITY TO INFLUENCE APOPTOSIS IN INDIAN CHILDHOOD CIRRHOSIS: PUMA IN THE CIRCUITPrasad, R. / Sharma, N. / Kaur, G. / Thapa, B. R. et al. | 2010
- S213
-
533 INCREASED PLATELET REACTIVE OXIGEN SPECIES (ROS) PRODUCTION IN EXPERIMENTAL CIRRHOSISRomecin, P. A. / Millan, J. E. / Meseguer, A. B. / Ortiz, M. C. / Gragnolini, F. / Garcia, E. M. / Atucha, N. / Garcia-Estann, J. et al. | 2010
- S214
-
535 HIGH BILIRUBIN REDUCES CELL SURVIVAL AND DIFFERENTIATION OF PRIMARY HUMAN OSTEOBLASTS. IS THIS EFFECT APPLICABLE TO THE SERUM OF CHRONIC CHOLESTATIC PATIENTS?Ruiz-Gaspa, S. / Martinez-Ferrer, A. / Enjuanes, A. / Peris, P. / Mertinez de Osaba, M. J. / Alvarez, L. / Monegal, A. / Combalia, A. / Guannabens, N. / Pares, A. et al. | 2010
- S216
-
541 IMPAIRED NEUTROPHIL PHAGOCYTIC CAPACITY IN PATIENTS WITH ADVANCED CIRRHOSIS IS RELATED TO THE DEVELOPMENT OF AMMONIA-INDUCED NEUTROPHIL SWELLINGTaylor, N. J. / Abeles, R. D. / Hussein, M. / Wendon, J. A. / Ma, Y. / Shawcross, D. L. et al. | 2010
- S217
-
544 S-NITROSO-N-ACETYLCYSTEINE ATTENUATES LIVER FIBROSIS IN AN ANIMAL MODEL OF CIRRHOSISTunnon, M. J. / Crespo, I. / Vercelino, R. / Cuevas, M. J. / San Miguel, B. / de Oliveira, M. / Marroni, N. P. / Gonzalez-Gallego, J. et al. | 2010
- S218
-
547 CHOLANGIOCARCINOMA IN ITALY: A NATIONAL SURVEY ON DEMOGRAPHIC AND CLINICAL CHARACTERISTICS, DIAGNOSTIC MODALITIES AND TREATMENTBragazzi, M. C. / Alvaro, D. / Benedetti, A. / Capocaccia, R. / Crocetti, E. / Fabris, L. / Fava, G. / Ferretti, S. / Floreani, A. / Grazi, G. L. et al. | 2010
- S219
-
550 DETECTABILITY OF CONTRAST-ENHANCED ULTRASONOGRAPHY USING SONAZOID FOR HEPATOCELLULAR CARCINOMAGoto, E. / Masuzaki, R. / Tateishi, R. / Uchino, K. / Arano, T. / Enooku, K. / Nakagawa, H. / Kondo, Y. / Goto, T. / Yoshida, H. et al. | 2010
- S220
-
553 DIFFERENTIAL GENE EXPRESSION PROFILE OF HEPATOBLASTOMA AND CHILDHOOD HEPATOCELLULAR CARCINOMA; ITS CLINICAL IMPLICATIONJin, J. / Park, S. Y. / Lee, K. / Kim, S. H. / Jang, J. J. et al. | 2010
- S221
-
556 COMPARISON OF DIAGNOSTIC CAPABILITY OF CONTRAST-ENHANCED CT, SONAZOID CONTRAST-ENHANCED US, GD-EOB-DTPA MRI AND CT ARTERIOPORTAL ANGIOGRAPHY IN DETECTING HISTOLOGICALLY PROVEN HCC NODULES SMALLER THAN 2CMKim, S. R. / Mita, K. / Maekawa, Y. / Kudo, M. / Imoto, S. / Nakajima, T. / Ando, K. / Fukuda, K. / Matsuoka, T. / Hayashi, Y. et al. | 2010
- S222
-
559 ANALYSIS OF A PROMOTER POLYMORPHISM OF THE GLUT1 GENE IN PATIENTS WITH HEPATOCELLULAR CARCINOMAKirovski, G. / Amann, T. / Bosserhoff, A. / Hellerbrand, C. et al. | 2010
- S223
-
562 TUMOR NECROSIS FACTOR-ALPHA PROMOTER GENE POLYMORPHISMS AFFECT THE OCCURRENCE OF HEPATOCELLULAR CARCINOMA IN PATIENTS WITH CHRONIC HEPATITIS BLee, D. / Chung, Y. H. / Kim, J. A. / Kim, S. E. / Choi, J. K. / Yoo, D. J. / Jin, Y. J. / Shim, J. H. / Lee, Y. S. et al. | 2010
- S224
-
565 ALPHA FETOPROTEIN PROMOTES THE EXPRESSION OF CXCR4 VIA INHIBITING THE ACTIVITY OF PTENLi, M. / Zhu, M. / Zhou, S. / Li, G. et al. | 2010
- S225
-
568 A NOVEL PROGNOSTIC ESTIMATION FORMULA FOR HEPATOCELLULAR CARCINOMA AFTER RESECTION, BASED ON TNM STAGING, TOTAL BILIRUBIN LEVEL, BLOOD LOSS, HLA-DR ALPHA AND DNA METHYLTRANSFERASE 1Lu, W. / Dong, J. / Bie, P. / Guo, D. / Zhang, W. / Cai, S. et al. | 2010
- S226
-
571 THE USEFULNESS OF GADOXETIC ACID (GD-EOB-DTPA)-ENHANCED MRI FOR THE QUANTITATIVE EVALUATION OF SMALL FOCAL LIVER LESIONS IN PATIENTS WITH CIRRHOSISMatsumoto, Y. / Kitamoto, M. / Igawa, A. / Hayashi, R. / Yamada, H. / Okazaki, H. / Nakahara, H. / Itamoto, T. et al. | 2010
- S227
-
574 ASSOCIATION OF GENETIC POLYMORPHISMS IN MITOCHONDRIAL ANTIOXIDANT SYSTEM WITH CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN HFE HEMOCHROMATOSISNahon, P. / Sutton, A. / Pessayre, D. / Rufat, P. / Charnaux, N. / Trinchet, J. C. / Beaugrand, M. / Deugnier, Y. et al. | 2010
- S228
-
577 HEPATOCELLULAR CARCINOMA IN BUDD-CHIARI SYNDROME: A SINGLE CENTER EXPERIENCE IN KOREAPark, H. N. / Yoon, J. Y. / Park, K. H. / Lee, J. M. / Kim, S. U. / Park, J. Y. / Kim, D. Y. / Ahn, S. H. / Han, K. H. / Chon, C. Y. et al. | 2010
- S229
-
580 HIGH CHROMOSOME INSTABILITY AND OCCASIONAL R249S TP53 MUTATION CHARACTERIZE HEPATOCELLULAR CARCINOMA IN ROMANIAMarchio, A. / Tanase, A. M. / Dumitrascu, T. / Mihaila, M. / Dima, S. / Dejean, A. / Popescu, I. / Oprisan, G. / Pineau, P. et al. | 2010
- S230
-
583 TUMOR RESPONSE IN A PHASE 2 STUDY OF FIRST-LINE BRIVANIB IN HEPATOCELLULAR CARCINOMA (HCC): COMPARISON OF MODIFIED WHO AND MODIFIED RECIST CRITERIARaoul, J. L. / Lencioni, R. / Park, J. W. / Baudelet, C. / Walters, I. et al. | 2010
- S231
-
585 A FRENCH MULTICENTRIC LONGITUDINAL DESCRIPTIVE STUDY OF HEPATOCELLULAR CARCINOMA MANAGEMENT (THE CHANGH COHORT): PRELIMINARY RESULTSRosa, I. / Denis, J. / Renard, P. / Lesgourgues, B. / Dobrin, A. S. / Becker, C. / Faroux, R. / Causse, X. / Diaz, E. / Le Dreau, G. et al. | 2010
- S233
-
591 TRANS ARTERIAL CHEMO-EMBOLIZATION (TACE) IS A SAFE AND EFFECTIVE TREATMENT FOR VERY ELDERLY PATIENTS WITH HEPATOCELLULR CARCINOMA (HCC)Cohen, M. J. / Levy, I. / Shouval, D. / Nesher, T. / Bloom, A. I. / Shibolet, O. et al. | 2010
- S234
-
595 VEGF, BFGF & ENDOSTATIN DO NOT PREDICT PROGNOSIS IN HEPATOCELLULAR CARSINOMA PATIENTSSykymbayev, A. / Eren, F. / Tiftikci, A. / Ture, F. / Gunduz, F. / Ozdogan, O. et al. | 2010
- S235
-
597 IMPACT OF CONTRAST-ENHANCED ULTRASONOGRAPHY ON DIAGNOSTIC WORK-UP OF FOCAL LIVER ANOMALIES: EXPERIENCE IN A SINGLE HEPATOLOGY UNITTarantino, L. / DeRosa, A. / Sorrentino, P. / Tambaro, O. / Celiento, M. / Del Prete, M. / Sabbatino, F. / Ripa, C. / Sordelli, I. / Nocera, V. et al. | 2010
- S237
-
603 DYNAMIC CONTRAST ENHANCED ULTRASOUND IN MONITORING HCC PATIENTS TREATED WITH SORAFENIB: PRELIMINARY RESULTSZocco, M. A. / Lupascu, A. / Riccardi, L. / Piscaglia, A. C. / Siciliani, L. / Novi, M. / Lauritano, E. C. / Tortora, A. / Gigante, G. / Santoro, M. et al. | 2010
- S238
-
606 DUAL ROLE OF STAT1/2 TRANSCRIPTION FACTORS IN CONTROLLING CCCDNA TRANSCRIPTION AND HBV REPLICATIONBelloni, L. / Guerrieri, F. / Scisciani, C. / Pollicino, T. / Raimondo, G. / Levrero, M. et al. | 2010
- S239
-
609 DOWN-REGULATION OF PD-1 EXPRESSION ON LYMPHOCYTES IN CHRONIC HEPATITIS B PATIENTS WITH PEGYLATED INTERFERON a-2b TREATMENT AND THE CORRELATION WITH CYTOKINESChen, J. / Wang, Y. / Wu, X. J. / Li, J. / Wang, G. Q. et al. | 2010
- S241
-
614 THE C-FLIP-NH2 TERMINUS (P22-FLIP) INHIBITS THE REPLICATION OF HEPATITIS B VIRUS (HBV) THROUGH THE INTERACTION WITH HBV X PROTEINKwon, S. Y. / Kim, K. H. / Park, Y. K. / Choe, W. H. / Lee, C. H. / Kwon, O. S. / Kim, Y. S. / Kim, J. H. et al. | 2010
- S242
-
617 CHARACTERISTICS OF HEPATITIS B VIRUS QUASISPECIES EVOLUTION DURING EARLY STAGE OF ENTECAVIR TREATMENT: A PROMISING PREDICTOR OF VIROLOGICAL RESPONSELiu, F. / Yu, D. M. / Huang, S. Y. / Yu, J. L. / Chen, L. / Zhang, X. X. et al. | 2010
- S243
-
620 THE INCREASED EXPRESSION OF 2B4 (CD244) ON NATURAL KILLER CELLS IN CHRONIC HEPATITIS B PATIENTS TREATED WITH TELBIVUDINEJiang, Y. F. / Li, W. Y. / Jin, Q. L. / Yan, H. Q. / Niu, J. Q. et al. | 2010
- S244
-
623 INCREASED CD39+ TREGS IN HBEAG - NEGATIVE CHRONIC HEPATITIS B PATIENTS CORRELATES WITH SERUM HBV DNAPetrova, M. / Nikolova, M. / Kamburov, V. / Nikolovska, D. / Taskov, H. / Krastev, Z. et al. | 2010
- S245
-
626 ULTRA-DEEP SEQUENCING ANALYSIS DEMONSTRATES PRE-EXISTENCE OF HBV RESISTANCE SUBSTITUTIONS AT BASELINE IN PATIENTS WHO SUBSEQUENTLY DEVELOP CLINICAL RESISTANCERodriguez, C. / Chevaliez, S. / Pallier, C. / Pawlotsky, J. M. et al. | 2010
- S249
-
638 IFN-a TREATMENT OF HEPATITIS B VIRUS (HBV)-INFECTED PRIMARY HUMAN HEPATOCYTES LEADS TO A SPECIFIC REDUCTION OF HBV MRNA LEVELSZhang, J. / Kock, J. / Blum, H. E. / Nassal, M. / Rasenack, J. / Baumert, T. / Thoma, C. et al. | 2010
- S250
-
641 DEVELOPMENT OF IN VITRO AND CELL-BASED ASSAYS FOR ASSESSING NUCLEOTIDE BIOSYNTHESIS INHIBITIONBalakireva, L. / Godard, N. et al. | 2010
- S252
-
646 NEUTRALIZATION OF HEPATITIS C IN CHRONICALLY INFECTED SUBJECTS: INFLUENCE OF HIV COINFECTION, LIVER TRANSPLANTATION AND SEVERITY OF LIVER DISEASEMaurin, G. / Halgand, B. / Colman, H. / Duclos-Vallee, J. C. / Samuel, D. / Cosset, F. L. / Lavillette, D. / Feray, C. et al. | 2010
- S253
-
649 MOLECULAR EPIDEMIOLOGY OF HEPATITIS C VIRUS GENOTYPE 5A IN FRANCE (A MULTICENTRE STUDY ANRS)Henquell, C. / Guglielmini, J. / Verbeeck, J. / Bailly, J. L. / Perez Serra, R. J. / Van Ranst, M. / Randl, K. / Bommelaer, G. / Peigue-Lafeuille, H. / Abergel, A. et al. | 2010
- S254
-
652 RECOMBINANT MAMMALIAN CELL DERIVED HEPATITIS C VIRUS LIKE PARTICLES INDUCE NEUTRALISING ANTIBODY AND B CELL RESPONSES TO HEPATITIS C VIRUSJohnson, D. F. / Chua, B. / Chin, R. / Earnest-Silveira, L. / Zentgraf, H. / Bock, C. T. / Zeng, W. / Jacskon, D. C. / Torresi, J. et al. | 2010
- S255
-
655 KINETIC INHIBITION PROFILES IN THE HEPATITIS C VIRUS REPLICON SYSTEM CAN INFORM ON COMPOUND MODE OF ACTIONShaw, S. / Lavender, H. et al. | 2010
- S256
-
658 HCV CONTRIBUTES TO INDUCE HEPATIC STEATOSIS DEREGULATING LIPID METABOLISM THROUGH LXR DEPENDING GENES MODULATIONArciello, M. / Petta, S. / Anticoli, S. / Mancinetti, A. / Iuliano, L. / Balsano, C. et al. | 2010
- S258
-
663 DIFFERENTIAL VIROLOGICAL AND CYTOKINE GENE EXPRESSION PROFILES IN LYMPHOID CELLS OF RESPONDERS AND NONRESPONDERS TO PEGYLATED INTERFERON ALPHA AND RIBAVIRIN COMBINATION THERAPYPham, T. / Lin, D. M. / Michalak, T. I. et al. | 2010
- S260
-
668 HCV INDUCES ACUTE AND CHRONIC ENDOPLASMIC RETICULUM (ER) STRESS, CAUSING ADAPTATION AND RESISTANCE TO ER STRESS INDUCED APOPTOSIS: A POSSIBLE VIRAL EVASION MECHANISMMerquiol, E. / Mezan, S. / Mills, M. / Tirosh, B. / Shibolet, O. et al. | 2010
- S261
-
671 NO EVIDENCE FOR DRUG RESISTANCE BY IMINOSUGAR-BASED HCV ASSEMBLY INHIBITORS IN TISSUE CULTURESteinmann, E. / Friesland, M. / Ciesek, S. / Zitzmann, N. / Pietschmann, T. et al. | 2010
- S262
-
674 LONG TERM FOLLOW-UP OF INJECTING DRUG USERS SUGGESTS PROTECTIVE IMMUNITY AGAINST HCV REINFECTION AND SUPERINFECTION WITH A SIMILAR GENOTYPEvan de Laar, T. J. / Rondy, M. / Bruisten, S. M. / Prins, M. / van Ballegooijen, M. et al. | 2010
- S263
-
677 FREQUENCY AND T-CELL RECEPTOR (TCR) REPERTOIRE OF HEPATITIS C VIRUS (HCV)-SPECIFIC CD8 T-CELLS IN HCV-SERONEGATIVE INDIVIDUALSBakshi, R. / Schlaphoff, V. / Suneetha, P. V. / Malinski, P. / Manns, M. P. / Wedemeyer, H. / Cornberg, M. et al. | 2010
- S264
-
679 CD127/PD-1 PHENOTYPE DEFINES THE HCV-SPECIFIC CYTOTOXIC T CELL REACTIVITY AFTER ANTIGEN ENCOUNTER DURING CHRONIC HEPATITIS C VIRUS INFECTIONLarrubia, J. / Benito-Martinez, S. / Miquel, J. / Calvino, M. / Sanz-de-Villalobos, E. / Gonzalez-Praetorius, A. / Albertos, S. / Parra-Cid, T. et al. | 2010
- S265
-
682 INNATE IMMUNE SYSTEM RESPONSES DIFFER DURING RECENT AND CHRONIC HEPATITIS C VIRUS INFECTIONBrun, P. / Boninsegna, S. / Palu, G. / Fabris, P. / Bitetto, D. / Toniutto, P. / Castagliuolo, I. / Martines, D. et al. | 2010
- S266
-
684 LIVER GENE EXPRESSION SIGNATURE TO PREDICT RESPONSE TO PEGYLATED INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS CDuces, A. / Bieche, I. / Jardin-Watelet, B. / Lapalus, M. / De Muynck, S. / Dupas, E. / Molina, I. / Lambert, N. / Nicolas, E. / Sallenave, B. et al. | 2010
- S267
-
687 AN INCREASED T-CELL REGULATORY ACTIVITY IN CHRONIC HEPATITIS C CORRELATES WITH NORMAL TRANSAMINASES, BUT ALSO WITH ADVANCED LIVER DISEASEFerri, S. / Lalanne, C. / Menichella, R. / Bassi, M. / De Molo, C. / Pappas, G. / Quarneti, C. / Muratori, P. / Belardinelli, A. R. / Bianchi, F. B. et al. | 2010
- S271
-
698 IMPAIRED REGULATORY ABILITY AND PREDOMINANCE OF THE GAMMA-DELTA VDELTA1 SUBSET IN PATIENTS WITH HCV-RELATED TYPE 2 CRYOGLOBULINEMIAFerri, S. / Menichella, R. / Lalanne, C. / Bassi, M. / Muratori, P. / Bianchi, F. B. / Muratori, L. / Lenzi, M. et al. | 2010
- S272
-
701 HOST GENETIC DETERMINANTS IN HCV-RELATED MIXED CRYOGLOBULINEMIAPiluso, A. / Gragnani, L. / Caini, P. / Fognani, E. / Giannini, C. / Monti, M. / Petrarca, A. / Ranieri, J. / Laffi, G. / Zignego, A. L. et al. | 2010
- S274
-
706 A DESENSITIZATION TO ALPHA-2 INTERFERON COULD ACCOUNT FOR NON-RESPONSE IN CHRONIC HEPATITIS CSultanik, P. / Andrieu, M. / Gaston, J. / Uze, G. / Pol, S. / Mallet, V. et al. | 2010
- S275
-
709 IDENTIFICATION OF PREDICTING FACTORS FOR SEROCONVERSION OF HEPATITIS B E ANTIGEN WITHIN A YEAR AMONG BIOCHEMICAL, PATHOLOGICAL AND VIROLOGICAL MARKERSBae, S. K. / Yatsuhashi, H. / Yano, K. / Fukuda, M. / Nakao, R. / Hamada, R. / Hashimoto, S. / Nishikawa, A. / Motoyoshi, Y. / Nagaoka, S. et al. | 2010
- S276
-
711 HEPATITIS B VIRUS (HBV) INFECTION IN BELGIUM: RESULTS OF THE BELGIAN ASSOCIATION FOR THE STUDY OF THE LIVER (BASL) REGISTRY OF 1421 HBSAG CHRONIC CARRIERSDeltenre, P. / Laleman, W. / van Gossum, M. / Lenaerts, A. / Colle, I. / Adler, M. / Michielsen, P. / Assene, C. / Delwaide, J. / Orlent, H. et al. | 2010
- S278
-
716 MOVING FROM PATIENT TO POPULATION-LEVEL HEPATITIS B MANAGEMENT IN AUSTRALIARobotin, M. C. / Kansil, M. / Howard, K. / George, J. et al. | 2010
- S279
-
719 A CROSS-SECTIONAL ANALYSIS OF CHRONIC HEPATITIS B PATIENT CHARACTERISTICS AND CLINICAL MANAGEMENT PATTERNS IN GERMANY, POLAND, ROMANIA AND TURKEYLescrauwaet, B. / Gwed, S. / Ponsonnet, D. / Arama, V. / Leblebicioglu, H. / Simon, K. / Zarski, J. P. / Zeuzem, S. et al. | 2010
- S282
-
726 GENOME-WIDE ASSOCIATION STUDY IDENTIFIES GENETIC VARIANTS IN THE HLA-DP LOCUS ASSOCIATED WITH CHRONIC HEPATITIS BMatsuura, K. / Tanaka, Y. / Nishida, N. / Hige, S. / Asahina, Y. / Ito, K. / Sugauchi, F. / Tokunaga, K. / Mizokami, M. et al. | 2010
- S283
-
729 HEPATITIS B VIRUS INFECTION IN IMMIGRANTS IN ROME: SCREENING, EPIDEMIOLOGICAL AND CLINICAL EVALUATIONNosotti, L. / DArca, T. / Pajno, C. / Marrone, R. / Uccella, I. / Morrone, A. et al. | 2010
- S284
-
731 CHANGES OF SERUM APOPTOTIC CASPASE ACTIVITY IN HBEAG-NEGATIVE CHRONIC HEPATITIS B (CHB) PATIENTS UNDER ORAL ANTIVIRAL THERAPYPapatheodoridis, G. V. / Giannousis, J. / Manolakopoulos, S. / Hadziyannis, E. / Georgiou, A. / Archimandritis, A. J. et al. | 2010
- S286
-
736 CHARACTERISTICS AND CLINICAL SIGNIFICANCE OF PERIPHERAL BLOOD NK CELLS SUBSETS IN PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTIONWu, C. / Liu, Y. / Wu, J. / Xu, L. / Yan, X. / Chen, J. et al. | 2010
- S287
-
738 CORRELATION OF CIRCULATING TLR1 - 10 EXPRESSION WITH PERIPHERAL BLOOD MONONUCLEAR CELLS IN CHRONIC HEPATITIS B AND RELATED LIVER FAILUREWang, K. / Liu, H. L. / He, Y. L. / Chen, T. Y. / Ye, F. / Liu, J. F. / Liu, M. / Ma, X. H. / Hao, X. J. / Zhang, S. L. et al. | 2010
- S288
-
741 FLUVASTATIN PROVIDES SYNERGISTIC ANTI-HCV ACTIVITY WHEN COMBINED WITH A POLYMERASE INHIBITOR, 2-CMA, IN VITROBader, T. / Zhang, Z. et al. | 2010
- S289
-
744 IN VIVO AND IN VITRO RESISTANCE TO SILIBININ, A COMPONENT OF SILYMARIN AND POTENT INHIBITOR OF HCV REPLICATIONChevaliez, S. / Ahmed-Belkacem, A. / Soulier, A. / Zinober, K. / Scherzer, T. M. / Brillet, R. / Ferenci, P. / Pawlotsky, J. M. et al. | 2010
- S290
-
746 NARLAPREVIR AND PEGINTERFERON ALFA-2B FOR 2 WEEKS IN CHRONIC HEPATITIS C GENOTYPE 1 PATIENTS, FOLLOWED BY PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR 24/48 WEEKS: FINAL RESULTSde Bruijne, J. / Bergmann, J. F. / Weegink, C. J. / Molenkamp, R. / Schinkel, J. / Treitel, M. A. / Hughes, E. A. / van Vliet, A. / de Knegt, R. J. / Reesink, H. W. et al. | 2010
- S291
-
749 EARLY ON-TREATMENT RESPONSES DURING PEGYLATED IFN PLUS RIBAVIRIN ARE INCREASED FOLLOWING 13 DAYS OF COMBINATION NUCLEOSIDE POLYMERASE (RG7128) AND PROTEASE (RG7227) INHIBITOR THERAPY (INFORM-1)Gane, E. / Roberts, S. / Stedman, C. / Angus, P. / Ritchie, B. / Elston, R. / Ipe, D. / Morcos, P. / Baher, L. / Najera, I. et al. | 2010
- S292
-
751 AVL-192: POTENCY AGAINST HCV NS3 MUTANTS ALLOWS FOR REPLICON CLEARANCE AS A MONOTHERAPY AND IN COMBINATION STUDIESHagel, M. / Niu, D. / St. Martin, T. / Sheets, M. / Qiao, L. / Chaturvedi, P. / Labenski, M. / Nacht, M. / Petter, R. / Singh, J. et al. | 2010
- S293
-
754 IMPACT OF RIBAVIRIN ON SUBGENOMIC HEPATITIS C VIRUS RNA DECAY DURING TREATMENT WITH INTERFERON ALFA AND THE PROTEASE INHIBITOR TELAPREVIRHofmann, W. P. / Osbahr, C. / Chung, T. L. / Susser, S. / Karey, U. / Mihm, U. / Welsch, C. / Sarrazin, C. / Zeuzem, S. / Herrmann, E. et al. | 2010
- S294
-
756 QUASISPECIES CHANGES DETECTED IN HYPERVARIABLE REGION 1 OF HEPATITIS C GENOME WITH HIGH-RESOLUTION DNA MELTING ANALYSIS IN TREATED AND UNTREATED CHRONIC HEPATITIS C PATIENTSHrstic, I. / Grahovac, B. / Mohar, B. / Kolaric, B. / Ostojic, R. / Vucelic, B. et al. | 2010
- S295
-
759 COMBINATION OF TMC435 WITH TWO NOVEL NS5B INHIBITORS INCREASES ANTI HCV ACTIVITY AND RESULTS IN A HIGHER GENETIC BARRIER IN VITROLenz, O. / Berke, J. M. / de Kock, H. / van Remoortere, P. / Nyanguile, O. / Vendeville, S. / Jonckers, T. / Raboisson, P. / Simmen, K. / Fanning, G. et al. | 2010
- S296
-
762 RESISTANCE PROFILE OF ABT-333 AND RELATIONSHIP TO VIRAL LOAD DECREASE IN PATIENTS TREATED IN COMBINATION WITH PEG-INTERFERON AND RIBAVIRIN FOR 28 DAYSMiddleton, T. / He, Y. / Beyer, J. / Menon, R. / Klein, C. / Cohen, D. / Collins, C. et al. | 2010
- S297
-
765 RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, DOSE RESPONSE (RPCDBDR) TRIAL OF CTS-1027, AN INHIBITOR OF MATRIX METALLOPROTEASES (MMPS) IN PATIENTS WITH HCV WHO HAD FAILED PRIOR THERAPIESPockros, P. J. / Gordon, S. C. / McCullough, A. / Charlton, M. / Bzowej, N. / Vierling, J. / Bansal, M. / Yoffe, B. / Everson, G. / Huyghe, M. et al. | 2010
- S298
-
768 IN VITRO ANTIVIRAL ACTIVITY OF IDX320, A NOVEL AND POTENT MACROCYCLIC HCV PROTEASE INHIBITORLallos, L. B. / Mccarville, J. / Li, B. / Bilello, J. P. / Lacolla, M. / Jakubik, J. / Soubasakos, M. A. / Gillum, J. / Serra, I. / Hubbard, L. et al. | 2010
- S301
-
776 GENETIC DIVERSITY IN THE LIGAND-BINDING SITE OF THE NS3.4A PROTEASE AND IMPACT ON PEPTIDOMIMETIC INHIBITORS IN HCV-1AWelsch, C. / Shimakami, T. / Hartmann, C. / Domingues, F. S. / Lengauer, T. / Lemon, S. / Zeuzem, S. et al. | 2010
- S302
-
778 PHASE IIB STUDY OF BALAPIRAVIR (RG1626; NUCLEOSIDE ANALOGUE INHIBITOR OF HCV POLYMERASE) PLUS PEGINTERFERON ALFA-2A (40KD) AND RIBAVIRIN FOR CHC GENOTYPE 1: FINAL RESULTSZeuzem, S. / Nelson, D. R. / Andreone, P. / Ferenci, P. / Herring, R. / Jensen, D. M. / Marcellin, P. / Pockros, P. / Rodriguez-Torres, M. / Rossaro, L. et al. | 2010
- S304
-
783 GLUCOCORTICOID-INDUCED LEUCINE ZIPPER (GILZ): A KEY PROTEIN IN THE SENSITIZATION OF FATTY LIVER TO LPS IN OBESITYBoujedidi, H. / Bigorgne, A. / Cassard-Doulcier, A. M. / Bouchet-Delbos, L. / Naveau, S. / Hamdi, H. / Durand-Gasselin, I. / Rousset, S. / Douard, R. / Chevallier, J. M. et al. | 2010
- S305
-
786 ROLE OF LXRALPHA AND ITS LIPOGENIC TARGET GENES IN THE PATHOGENESIS OF HCV-RELATED STEATOSIS IN AN IN VITRO MODELGarcia-Mediavilla, M. V. / Lima, E. / Pisonero-Vaquero, S. / Merino-Antolin, B. / Majano, P. L. / Benedicto, I. / Olcoz, J. L. / Gonzalez-Gallego, J. / Sanchez-Campos, S. et al. | 2010
- S307
-
791 BENEFICIAL EFFECTS OF CANNABINOID RECEPTOR 2 ON ALCOHOLIC LIVER DISEASELouvet, A. / Teixeira-Clerc, F. / Deveaux, V. / Chobert, M. N. / Pavoine, C. / Mallat, A. / Lotersztajn, S. et al. | 2010
- S308
-
794 TARGETED GENETIC MODULATION OF HEME OXYGENASE-1 PROTECTS AGAINST HEPATOCYTE APOPTOSIS IN MICENan, Y. M. / Wang, R. Q. / Han, F. / Wu, W. J. / Zhao, S. X. / Liang, B. L. / Fu, N. / Yu, J. et al. | 2010
- S309
-
797 METABOLIC EFFECTS OF THE GENETIC ABLATION OF MTOR OR PHARMACOLOGICAL INHIBITION OF MTOR IN MICE LACKING HEPATIC EXPRESSION OF PTENPiguet, A. C. / Thomas, H. E. / Ledermann, M. / Kozma, S. C. / Dufour, J. F. et al. | 2010
- S311
-
802 CELL SURFACE PANTETHEINASE, VANIN-1, INCREASES OXIDATIVE DAMAGE IN ACETAMINOPHEN INDUCED LIVER INJURY VIA A REDUCTION IN GLUTATHIONEMatthews, H. C. / Concas, D. / Kudo, H. / Anstee, Q. / Thomas, H. / Cox, R. / Goldin, R. D. / Thursz, M. R. et al. | 2010
- S313
-
807 DIAGNOSTIC VALUE OF ULTRASOUND IN DETECTION OF BILIARY COMPLICATIONS AFTER LIVER TRANSPLANTATIONBoozari, B. / Negm, A. / Hahn, A. / Kubicka, S. / Schneider, A. / Wedemeyer, J. / Klempnauer, J. / Manns, M. / Gebel, M. et al. | 2010
- S314
-
810 PRIOR HEPATIC ENCEPHALOPATHY AND ALCOHOL ETIOLOGY DETERMINE COGNITIVE FUNCTION AFTER LIVER TRANSPLANTATIONGarcia-Martinez, R. / Jacas, C. / Alonso, J. / Vargas, V. / Simon-Talero, M. / Cordoba, J. et al. | 2010
- S315
-
813 RESULTS OF LIVER TRANSPLANTATION IN ADULT POLYCYSTIC LIVER DISEASE: REPORT OF A SINGLE CENTER EXPERIENCEPatris, A. / Bonaccorsi-Riani, E. / Ciccarelli, O. / Goffette, P. / Pirson, Y. / Lerut, J. / Hassoun, Z. et al. | 2010
- S316
-
816 DUCTULAR REACTION IN HEPATITIS C RECURRENCE POST LIVER TRANSPLANTATIONPrakoso, E. / Kench, J. / Clouston, A. / Bowen, D. / McCaughan, G. / Shackel, N. et al. | 2010
- S319
-
819 IMPROVEMENT OF SURVIVAL IN A SWINE MODEL OF ACUTE LIVER FAILURE BY A NEW LIVER SUPPORT SYSTEM (HEPA WASH)Al-Chalabi, A. / Matevossian, E. / Preissel, A. K. / Yang, Z. / Schreiber, C. / Schimmel, P. / Nairz, E. / Yan, H. / Geiger, A. / Kreymann, B. et al. | 2010
- S320
-
822 THE CLINICAL FEATURES AND OUTCOME OF ACUTE LIVER FAILURE (ALF) IN MALAYSIAChe-Hamzah, N. A. / Tan, S. S. et al. | 2010
- S322
-
827 PROGNOSTICATING VALUE OF ALTERED SERUM-SOLUBLE CD40L LEVELS AND CD40 EXPRESSION ON MONOCYTES IN FULMINANT HEPATIC FAILUREZheng, Y. B. / Xie, S. B. / Xie, D. Y. / Zhang, Y. F. / Zhang, X. H. / Lin, B. L. / Zhao, Z. X. / Chong, Y. T. / Gao, Z. L. et al. | 2010
- S323
-
829 SAFETY AND EFFICACY OF THE EXTRACORPOREAL LIVER ASSIST DEVICE (ELAD) IN PATIENTS WITH ACUTE ON CHRONIC LIVER FAILUREHillebrand, D. J. / Frederick, R. T. / Williams, W. W. / Brown, R. S. / Napotilano, L. M. / Te, H. S. / Millis, J. M. / Ashley, R. A. / Pockros, P. J. et al. | 2010
- S324
-
831 OUTCOME PREDICTION MODELS TO DETERMINE THE INDICATIONS OF LIVER TRANSPLANTATION IN PATIENTS WITH ACUTE LIVER FAILURE: DATA MINING USING DECISION TREE LEARNING AND RBF NETWORKNakayama, N. / Nagoshi, S. / Fujiwara, K. / Oketani, M. / Tsubouchi, H. / Kawamura, Y. / Mochida, S. et al. | 2010
- S325
-
834 DESIGNING LIVER CELLS CAPABLE OF AMMONIA DETOXIFICATION USEFUL IN BIO-ARTIFICIAL LIVERRajebhosale, M. / Selden, C. / Hodgson, H. et al. | 2010
- S326
-
837 APPLICATION OF GENE MODIFIED XENOGENEIC BMSCS: A BRIDGE TO LIVER TRANSPLANTATIONWang, H. / Zhang, X. / Wan, Z. / Lv, Y. et al. | 2010
- S328
-
842 A RANDOMIZED TRIAL OF ENDOSCOPIC BAND LIGATION VERSUS CYANOACRYLATE INJECTION IN THE MANAGEMENT OF BLEEDING JUNCTIONAL VARICESEl Amin, H. / Baki, L. A. / Sayed, Z. E. / Fouad, Y. M. / Abdel-Mohsen, E. / Eid, K. A. / El-Khayat, H. R. et al. | 2010
- S329
-
845 LIVER, RENAL, AND CIRCULATORY DYSFUNCTION IN HEPATORENAL SYNDROME WITH AND WITHOUT BACTERIAL INFECTION. A PROSPECTIVE STUDYGuevara, M. / Llahi, M. M. / Marinelli, M. / Fagundes, C. / Pereira, G. / Sola, E. / Pavesi, M. / Fernandez, J. / Arroyo, V. / Gines, P. et al. | 2010
- S330
-
848 THE EVALUATION OF MULTISPECIES PROBIOTICS IN PORTAL HYPERTENSION - CYTOKINES INVOLVED IN THE PATHOGENESIS OF HEPATO-RENAL SYNDROME ARE NOT MANIPULATEDMarlicz, W. M. / Wunsch, E. / Mydlowska, M. / Czyszek, J. / Milkiewicz, M. / Milkiewicz, P. et al. | 2010
- S331
-
851 EFFECT OF ANGIOTENSIN RECEPTOR BLOCKERS IN REDUCING PORTAL PRESSURE IN CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION: THE ENRICH STUDYNomorosa, M. / Zamora, R. / Lim, A. S. / Banez, V. et al. | 2010
- S332
-
854 BACTERIAL DNA IS RARELY DETECTED IN THE SERUM AND THE ASCITIC FLUID OF NONINFECTED OUTPATIENTS WITH CIRRHOSIS AND ASCITES TREATED BY PARACENTESISSerste, T. / Bert, F. / Leflon-Guibout, V. / Chauveau, C. / Asselah, T. / Francoz, C. / Durand, F. / Lebrec, D. / Valla, D. / Moreau, R. et al. | 2010
- S334
-
859 EFFECT OF FUZHENG HUAYU CAPSULE ON PREVENTING ESOPHAGEAL VARICEAL BLEEDING IN CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION: A LONG-TIME FOLLOW-UP STUDYXu, L. / Gu, J. / Xiao, D. et al. | 2010
- S336
-
864 COMBINING SUBCUTANEOUS INOCULATION OF AFP-EXPRESSING DC WITH INTRAPERITONEAL INJECTION OF IL-12-EXPRESSING DC INCREASES SURVIVAL IN AN ESTABLISHED ORTHOTOPIC HCC MODELDecker, G. / Vogt, A. / Bahadori, I. / Raskopf, E. / Schmitz, V. / Sauerbruch, T. / Caselmann, W. H. / Gonzalez-Carmona, M. A. et al. | 2010
- S337
-
867 THE ROLE OF MICRORNA-125B REPRESSION IN THE PATHOGENESIS OF HEPATOCELLULAR CARCINOMAElfimova, N. / Quasdorff, M. / Strack, I. / Noetel, A. / Riemer, J. / Goeser, T. / Kwiecinski, M. / Protzer, U. / Dienes, H. P. / Odenthal, M. et al. | 2010
- S339
-
872 RETROVIRAL INSERTIONAL MUTAGENESIS IDENTIFIED THE SERINE-THREONINE KINASE RIPK4 AS PUTATIVE NOVEL TUMOR SUPPRESSOR IN HUMAN HEPATOCARCINOGENESISHeim, D. / Cornils, K. / Fehse, B. / Lohse, A. W. / Brummendorf, T. H. / Wege, H. et al. | 2010
- S341
-
876 COFFEE MEDIATED UPREGULATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASESKalthoff, S. / Ehmer, U. / Freiberg, N. / Manns, M. / Strassburg, C. et al. | 2010
- S342
-
879 PRECLINICAL STUDY OF NEW NANOPARTICLES WITH ANTICANCER AND MRI FUNCTIONSLee, J. W. / Lee, J. I. / Lee, D. H. / Kim, Y. S. / Hong, S. S. / Maeng, J. H. / Jung, K. H. et al. | 2010
- S343
-
881 COMBINATION THERAPY WITH EGFR1-2/VEGFR INHIBITOR (XL647) AND SORAFENIB IMPROVES OUTCOMES IN A PRE-CLINICAL MODEL OF HCCMinguez, B. / Toffanin, S. / Lachenmayer, A. / Cabellos, L. / Villanueva, A. / DiFeo, A. / Melgar-Lesmes, P. / Thung, S. / Friedman, S. L. / Llovet, J. M. et al. | 2010
- S345
-
888 CAP-INDEPENDENT TRANSLATION OF LAMININ B1 DURING LIVER CANCER PROGRESSIONPetz, M. / Hau, M. / Huber, H. / Mikulits, W. et al. | 2010
- S346
-
890 HETEROGENEITY IN PRIMARY HUMAN HEPATOCELLULAR CARCINOMA IS DUE TO DIFFERENT SUBSETS OF CANCER STEM-LIKE CELLS WITHIN THE TUMOURBaldan, F. / Mazzucchelli, S. / Colombo, F. / Martin-Padura, I. / Cattaneo, A. / Rossi, G. / Mazzaferro, V. / Foglieni, B. / Bertolini, F. / Prati, D. et al. | 2010
- S347
-
893 SERIAL DECREASE OF PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVELS AFTER TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION MAY PREDICT EFFECTIVENESS OF PROCEDURE; A PROSPECTIVE STUDYRyu, S. H. / Park, J. H. / Kim, H. H. / Kim, J. A. / Lee, J. H. / Kim, Y. S. / Moon, J. S. et al. | 2010
- S348
-
896 HEPACAM, A NEW IG-LIKE CELL ADHESION MOLECULE INDENTIFIED IN THE LIVERShen, S. et al. | 2010
- S349
-
899 MICRORNA EXPRESSION OF KERATIN 19 POSITIVE HEPATOCELLULAR CARCINOMAS INDICATES STRONG TUMOUR PROGRESSION AND INVASIONGovaere, O. / Spee, B. / Verslype, C. / Aerts, R. / Topal, B. / Nevens, F. / Roskams, T. et al. | 2010
- S350
-
902 THE P53 FAMILY TARGET GENE SIGNATURE IS OF PROGNOSTIC RELEVANCE IN HEPATOCELLULAR CARCINOMAStaib, F. / Mundt, H. / Koch, A. / Krupp, M. / Galle, P. R. / Stremmel, W. / Teufel, A. / Muller, M. et al. | 2010
- S351
-
905 A UNIQUE HUMAN MODEL OF EPITHELIAL TO MESENCHYMAL TRANSITION REVEALS AXL AS A KEY REGULATOR OF HEPATOCELLULAR CARCINOMA PROGRESSIONvan Zijl, F. / Mall, S. / Machat, G. / Bauer, T. / Pirker, C. / Strobl, H. / Berger, W. / Bilban, M. / Mikulits, W. et al. | 2010
- S352
-
908 RELATIONSHIP OF INSULIN-LIKE GROWTH FACTORS SYSTEM GENE POLYMORPHISMS WITH SUSCEPTIBILITY AND PATHOLOGICAL DEVELOPMENT OF HEPATOCELLULAR CARCINOMAYang, S. F. / Chu, Y. H. / Chiou, H. L. et al. | 2010
- S353
-
911 DIFFERENTIATION OF TRANSFECTED HUMAN UMBILICAL CORD BLOOD STEM CELLS IN THE REGENERATING LIVER OF RATSAndreeva, D. / Gazizov, I. / Ilmaz, T. / Kaligin, M. / Gumerova, A. / Kiyasov, A. / Rizvanov, A. et al. | 2010
- S354
-
914 CELL-SPECIFIC TARGETING OF INTERFERON GAMMA TO HEPATIC STELLATE CELLS USING A CYCLIC PDGF-RECEPTOR RECOGNIZING PEPTIDE IMPROVES ITS THERAPEUTIC EFFICACYBansal, R. / Prakash, J. / Post, E. / Beljaars, L. / Poelstra, K. et al. | 2010
- S356
-
919 ZONAL ENDOTHELIAL CELL HETEROGENEITY IN THE HUMAN HEPATIC LOBULE: FURTHER EVIDENCE AND PHYSIOPATHOLOGICAL CONSEQUENCESBorghi-Scoazec, G. / Scoazec, J. Y. et al. | 2010
- S358
-
924 CF102 INDUCES APOPTOSIS OF LIVER CANCER WHILE PREVENTING APOPTOSIS IN LIVER INFLAMMATION: A NEW APPROACH TO TREAT LIVER DISEASESCohen, S. / Stemmer, S. M. / Zozulya, G. / Ochaion, A. / Patoka, R. / Barer, F. / Bar Yehuda, S. / Rath-Wolfson, L. / Fishman, P. et al. | 2010
- S359
-
927 ER-STRESS ACTIVATION IN HUMAN HEPATOCELLULAR CANCER CELLS: AN ALTERNATIVE DEATH PATHWAY INDUCED BY PANOBINOSTATDi Fazio, P. / Montalbano, R. / Quint, K. / Ocker, M. et al. | 2010
- S360
-
930 IDENTIFICATION OF MICRORNAS DURING RAT LIVER REGENERATION AFTER PARTIAL HEPATECTOMY AND MODULATION BY URSODEOXYCHOLIC ACIDCastro, R. E. / Zhang, X. / Ferreira, D. M. / Borralho, P. M. / Sarver, A. L. / Zeng, Y. / Steer, C. J. / Kren, B. T. / Rodrigues, C. M. et al. | 2010
- S361
-
933 MICRORNA-221 TARGETS PUMA AND SENSITIZES HUMAN HEPATOCELLULAR CARCINOMA CELLS TO DOXORUBICIN TREATMENTFornari, F. / Gramantieri, L. / Milazzo, M. / Pollutri, D. / Grazi, G. L. / Negrini, M. / Bolondi, L. et al. | 2010
- S363
-
938 GLUCOSYLCERAMIDE INHIBIT IL-6/STAT3 SIGNALING PATHWAY AND LEADS TO AN IMPAIRMENT OF LIVER REGENERATIONGretchen, I. / Sandhoff, R. / Gonzalez-Carmona, M. / Weber, S. / Buttner, R. / Lammert, F. / Sauerbruch, T. / Yildiz, Y. et al. | 2010
- S364
-
941 REGULATION OF THE HEPATOCELLULAR RESPONSE TO ENDOPLASMIC RETICULUM STRESS BY THE TRANSCRIPTION FACTOR C-JUN/AP-1Fuest, M. / Willim, K. / Blum, H. E. / Hasselblatt, P. et al. | 2010
- S365
-
944 THERAPEUTIC POTENTIAL OF HUMAN PLACENTA-DERIVED STEM CELLS IN THE CCL4-INJURED RATS DEPENDS ON TRANSPLANTATION ROUTESKim, G. J. / Hwang, S. G. / Jung, J. / Lee, M. J. / Kim, G. I. / Kwon, S. W. / Rim, K. S. et al. | 2010
- S366
-
947 EFFICACY OF AUTOLOGOUS MESENCHYMAL STEM CELL TRANSPLANTATION IN PATIENTS WITH LIVER CIRRHOSIS: THE PRELIMINARY RESULTSKantarcioglu, M. / Avcu, F. / Ozcan, A. / Guvenc, I. / Uygun, A. / Ural, A. U. / Bagci, S. et al. | 2010
- S367
-
950 IMMUNOGENICITY OF MOUSE ESC-DERIVED CELLS IN DIFFERENT STAGES OF HEPATIC LINEAGE DEVELOPMENT: MHC EXPRESSION PROFILES AND IMPLICATION OF ALLOGRAFT REJECTIONWu, G. D. / Zhao, X. / Klein, A. et al. | 2010
- S370
-
958 HEPATIC PROGENITOR CELL (HPCS) EXPANSION IN HUMAN CHRONIC VIRAL HEPATITIS B AND CLorenzini, S. / Grandini, E. / Panno, A. M. / Amati, E. / Bernardi, M. / Forbes, S. J. / Andreone, P. et al. | 2010
- S372
-
963 CDKN1C/P57 INDUCES CELL SENESCENCE AND IS REGULATED BY NOTCH TARGET GENE HES1, A PROGNOSTIC FACTOR IN HEPATOCELLULAR CARCINOMAMinguzzi, M. / Giovannini, C. / Gramantieri, L. / Fornari, F. / Chieco, P. / Bolondi, L. et al. | 2010
- S373
-
966 DOWN-REGULATION OF SREBP-1C IS ASSOCIATED WITH THE DEVELOPMENT OF BURNED-OUT NASHNagaya, T. / Tanaka, N. / Komatsu, M. / Joshita, S. / Umemura, T. / Ichijo, T. / Matsumoto, A. / Yoshizawa, K. / Aoyama, T. / Tanaka, E. et al. | 2010
- S374
-
969 CYCLIN E1 CONTROLS THE CELL CYCLE ACTIVITY OF HEPATIC STELLATE CELLS AND TRIGGERS FIBROGENESIS IN MICENevzorova, Y. A. / Bangen, J. M. / Gassler, N. / Haas, U. / Weiskirchen, R. / Tacke, F. / Sicinski, P. / Trautwein, C. / Liedtke, C. et al. | 2010
- S376
-
974 NUCLEAR FACTOR KAPPA B IS REQUIRED FOR SERUM FREE INDUCED ACTIVATION AND CHROMATIN ACCESSIBILITY OF DAMAGE-REGULATED AUTOPHAGY MODULATOR PROMOTER IN LIVER CANCER CELLSPeihua, N. / Jiayi, W. / Zhidong, G. / Qishi, F. et al. | 2010
- S377
-
977 INHIBITION OF NITRIC OXIDE SYNTHESIS DURING INDUCED CHOLESTASIS AMELIORATES HEPATOCELLULAR INJURY BY FACILITATING S-NITROSOTHIOL HOMEOSTASISLopez-Sanchez, L. M. / Corrales, F. J. / Barcos, M. / Espejo, I. / Munnoz-Castanneda, J. R. / Rodriguez-Ariza, A. et al. | 2010
- S378
-
980 HEPCIDIN IS RESPONSIVE TO ORAL IRON CHALLENGE IN HEALTHY VOLUNTEERSSangwaiya, A. / Busbridge, M. / Manglam, V. / Thursz, M. / Arnold, J. et al. | 2010
- S379
-
982 BMI1 IS A MARKER OF ACTIVATED LIVER PROGENITOR CELLSSchotanus, B. A. / Spee, B. / Kruitwagen, H. S. / Brinkhof, B. B. / van den Ingh, T. S. / Penning, L. C. / Roskams, T. et al. | 2010
- S380
-
985 THE NOVEL ENDOCANNABINOID VIRODHAMINE SELECTIVELY INDUCES CELL DEATH IN HEPATIC STELLATE CELLSWojtalla, A. / Herweck, F. / Singer, M. V. / Zimmer, A. / Siegmund, S. V. et al. | 2010
- S381
-
988 S-NITROSO-N-ACETYLCYSTEINE (SNAC), A NITRIC OXIDE DONOR, MODULATED HEPATIC STELLATE CELLS (HSCS) ACTIVITY: A NEW ANTIFIBROGENIC AGENTStefano, J. T. / Cogliati, B. / Oliveira, F. S. / Lima, V. M. / de Souza, G. F. / Uribe, C. / de Oliveira, M. G. / Matte, U. / Dagli, M. L. / Alvares-da-Silva, M. R. et al. | 2010
- S383
-
993 THE EFFECT OF IMPAIRED HEPATIC LIPOGENESIS ON LIVER REGENERATION IN A MODEL OF DIPEPTIDYL PEPTIDASE 4-DEFICIENT RATSWaizbard, A. / Schnell, M. / Zvibel, I. / Phillips, A. / Halpern, Z. / Oren, R. et al. | 2010
- S384
-
996 HUMAN POLYCYSTIC LIVER CYST FLUID INDUCED CHOLANGIOCYTE PROLIFERATION IS REVERSED BY LANREOTIDE IN A SOMATOSTATIN RECEPTOR 5 AND PHOSPHODIESTERASE 4D DEPENDENT MECHANISMWoudenberg, J. / Janssen, M. J. / Worm, I. / Te Morsche, R. H. / Chrispijn, M. / Drenth, J. P. et al. | 2010
- S385
-
999 HUMAN MONOCYTE SUBSETS ACCUMULATE INTRAHEPATICALLY IN LIVER CIRRHOSIS AND DIFFERENTIALLY INTERACT WITH HEPATIC STELLATE CELLSZimmermann, H. W. / Seidler, S. / Nattermann, J. / Gassler, N. / Hellerbrand, C. / Weiskirchen, R. / Trautwein, C. / Tacke, F. et al. | 2010
- S386
-
1001 PRAGMATIC ASSESSMENT OF LIVER FIBROSIS DURING METHOTREXATE THERAPY: COMPARISON OF PATIENTS WITH PSORIASIS, RHEUMATOID ARTHRITIS OR CROHNS DISEASEAlby-Lepresle, B. / Cervoni, J. P. / Monnet, E. / Aubin, F. / Wendling, D. / Toussirot, E. / Mermet, I. / Nachury, M. / Bertolini, E. / Carbonnel, F. et al. | 2010
- S387
-
1004 A PROSPECTIVE COHORT STUDY ON ENTECAVIR TREATING PATIENTS WITH ACUTE ON CHRONIC HEPATITIS B LIVE FAILURE (ACHBLF)Bingliang, L. / Dongying, X. / Junqiang, X. / Xiaohong, Z. / Shibing, X. / Yubo, H. / Zhiliang, G. et al. | 2010
- S388
-
1007 RISK OF RENAL TOXICITY WITH TENOFOVIR DF (TDF) FOR CHRONIC HEPATITIS B (CHB)Gish, R. / Mangahas, M. / Baqai, S. / Shaw, R. et al. | 2010
- S389
-
1009 EFFECTIVENESS OF ENTECAVIR FOR NUC-NAIVE, HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS IN CLINICAL PRACTICE: A 2-YEAR MULTICENTER COHORT STUDY IN 311 PATIENTSLampertico, P. / Vigano, M. / Facchetti, F. / Minola, E. / Fracassetti, O. / Suter, F. / Zaltron, S. / Puoti, M. / Carosi, G. / Gubertini, G. et al. | 2010
- S390
-
1011 RISK AND PREDICTORS OF MORTALITY OR HEPATOCELLULAR CARCINOMA AMONG ENTECAVIR- OR ADEFOVIR-TREATED CHRONIC HEPATITIS B PATIENTS WITH EVIDENCE OF HEPATIC DECOMPENSATIONLiaw, Y. F. / Raptopoulou-Gigi, M. / Cheinquer, H. / Sarin, S. K. / Tanwandee, T. / Leung, N. / Peng, C. Y. / Myers, R. P. / Brown, R. S. / Tsai, N. et al. | 2010
- S393
-
1018 EXPOSURE-VIRAL RESPONSE ANALYSES OF THE NON-NUCLEOSIDE POLYMERASE INHIBITOR ABT-333, FOLLOWING MONOTHERAPY AND ABT-333 PLUS PEGYLATED INTERFERON AND RIBAVIRIN THERAPYMensing, S. / Menon, R. / Klein, C. / Diderichsen, P. / Kaefer, A. / Noertersheuser, P. / Awni, W. et al. | 2010
- S394
-
1020 SAFETY AND EFFICACY OF ENTECAVIR AND TENOFOVIR COMBINATION-THERAPY IN HEPATITIS B PATIENTS WITH PREVIOUS TREATMENT FAILURES. AN INTERNATIONAL MULTICENTER COHORT STUDYPetersen, J. / Lutgehetmann, M. / Zoulim, F. / Janssen, H. / Sterneck, M. / Brown, A. / Berg, T. / Buggisch, P. / Lampertico, P. / Buti, M. et al. | 2010
- S395
-
1023 ADHERENCE TO ANTI-HBV ANALOGUES IN CLINICAL PRACTICE IS ASSOCIATED WITH VIROLOGICAL EFFICACY AND DEPENDS ON THE DURATION OF TREATMENTS AND THE PHYSICIANS EXPERIENCESogni, P. / Fontaine, H. / Mallet, V. / Vallet-Pichard, A. / Trabut, J. B. / Meritet, J. F. / Carrieri, M. P. / Pol, S. et al. | 2010
- S396
-
1025 THE GENETIC BARRIER MODULATES THE IMMUNE ESCAPE POTENTIAL OF HBV GENOTYPESSvicher, V. / Cento, V. / Salpini, R. / Merucurio, F. / Han, Y. / Gori, C. / Wittkop, L. / Fraune, M. / Bertoli, A. / Micheli, V. et al. | 2010
- S399
-
1032 THE EXPRESSION OF PD-1 ON PERIPHERAL BLOOD T CELLS DECREASED RAPIDLY IN EARLY ANTIVIRAL TREATMENT COULD PREDICT HBEAG SEROCONVERSION IN CHBWu, C. / Chen, J. / Liu, Y. / Xu, L. / Wu, J. / Yan, X. et al. | 2010
- S400
-
1034 COMBINATION OF TWO COMPLEMENTARY NUCLEOTIDE ANALOGUES PSI-7977 AND PSI-938 EFFECTIVELY CLEARS WILD TYPE AND NS5B:S282T HCV REPLICONS - COMPARISON WITH COMBINATIONS OF OTHER ANTIVIRAL COMPOUNDSZennou, V. / Lam, A. M. / Keilman, M. / Steuer, H. M. / Espiritu, C. / Sofia, M. J. / Reddy, P. G. / Chang, W. / Rachakonda, S. / Otto, M. J. et al. | 2010
- S401
-
1037 HCV INFECTION IMPAIRS GLUCOSE METABOLISM WHICH PROMOTES A MORE AGGRESSIVE COURSE OF LIVER DISEASE AND METABOLIC SYNDROMEAdinolfi, L. E. / Zampino, R. / Restivo, L. / Guerrera, B. / Santoro, A. / Ciervo, A. / Rinaldi, L. / Scialdone, V. R. / Ferrara, M. / Ruggiero, G. et al. | 2010
- S404
-
1045 SERUM OSTEOPROTEGERIN, A NEW SERUM MARKER OF LIVER FIBROSISBosselut, N. / Guechot, J. / Zarski, J. P. / Barbu, V. / Lasnier, E. / Baudin, B. / Housset, C. / Vaubourdolle, M. et al. | 2010
- S406
-
1050 HEPATITIS C VIRUS INFECTION AND MORTALITY FROM LIVER RELATED DISEASELee, M. H. / Yang, H. I. / Jen, C. L. / You, S. L. / Chen, C. J. et al. | 2010
- S407
-
1053 ASSOCIATION BETWEEN DIABETES MELLITUS, HEPATIC STEATOSIS AND FIBROSIS IN CHRONIC HEPATITIS C PATIENTS IN TAIWANDai, C. Y. / Huang, J. F. / Hsieh, M. Y. / Hou, N. J. / Lin, Z. Y. / Chen, S. C. / Wang, L. Y. / Chuang, W. L. / Yu, M. L. et al. | 2010
- S408
-
1056 DRIED BLOOD SPOT FOR HEPATITIS C VIRUS MOLECULAR DIAGNOSIS: AN ALTERNATIVE TOOL FOR HARD-TO-REACH POPULATIONTuaillon, E. / Mondain, A. M. / Meroueh, F. / Ottomani, L. / Van de Perre, P. / Ducos, J. et al. | 2010
- S409
-
1059 POSSIBLE ROLE OF ANGIOTENSIN CONVERTING ENZYME POLYMORPHISM ON PROGRESSION OF HEPATIC FIBROSIS IN CHRONIC HEPATITIS C VIRUS INFECTIONElhosary, Y. / Raslan, H. M. / Abdulla, N. A. / Elsayed, K. / Ezzat, W. M. / El-Batae, H. E. et al. | 2010
- S410
-
1062 NO EVIDENCE FOR AN IMPACT ON MORTALITY IN CHRONICALLY HCV INFECTED DRUG USERSGrady, B. P. / Krol, A. / van den Berg, C. / van der Helm, J. / Schinkel, J. / Coutinho, R. / Prins, M. et al. | 2010
- S411
-
1064 ELISPOT TESTING SHOWS VERY FEW INJECTING DRUG USERS AVOID HEPATITIS C VIRUS EXPOSUREHellard, M. / Sacks-Davis, R. / Higgs, P. / Bharadwaj, M. / Bowden, D. / Drummer, H. / Aitken, C. et al. | 2010
- S413
-
1069 EVALUATION OF ANTIBODIES TO MULTIPLE CORE PEPTIDES IN PATIENTS WITH OCCULT HCV INFECTIONQuiroga, J. A. / Castillo, I. / Bartolome, J. / Llorente, S. / Barril, G. / Carrenno, V. et al. | 2010
- S415
-
1074 INFLUENCE OF NICOTINE ABUSE ON FIBROSIS PROGRESSION IN CHRONIC HEPATITIS C VIRUS (HCV) INFECTIONSchafer, A. / Kriener, S. / Paul, K. / Zeuzem, S. / Scheurlen, M. / Teuber, G. et al. | 2010
- S416
-
1077 OXIDATIVE STRESS IS THE MAIN CAUSE OF STEATOSIS ESPECIALLY IN HCV GENOTYPE 3A. ASSOCIATION TO LIPID DEREGULATION IN THE ABSENCE OF INSULIN RESISTANCEMarinho, C. / Serejo, F. / Baldaia, C. / Esteves, A. / Bicho, M. / Velosa, J. et al. | 2010
- S417
-
1080 DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF HEPATITIS C PATIENTS WITH AND WITHOUT DIABETES: THE MANAGED CARE EXPERIENCEShire, N. J. / Shvachtko, V. A. / Murphy, R. C. / Darbanian, J. A. / Arduino, J. M. / Manos, M. M. et al. | 2010
- S419
-
1085 VIRAL HEPATITIS B AND C IN NEWLY DIAGNOSED HIV-1 INDIVIDUALS IN SPAIN - A NATIONAL SURVEY SINCE YEAR 2000Trevinno, A. / Rodriguez, C. / Parra, P. / Rivas, P. / Herrero-Mendoza, M. D. / del Romero, J. / Soriano, V. / de Mendoza, C. et al. | 2010
- S421
-
1090 LOW SERUM IL-17 LEVEL MAY PREDICT HIGH INFLAMMATORY ACTIVITY WITHIN THE LIVER IN NAIVE PATIENTS WITH AUTOIMMUNE HEPATITISGutkowski, K. / Kacperek-Hartleb, T. / Kajor, M. / Mazur, W. / Boryczka, G. / Hartleb, M. / Kaminska-Kiszka, E. et al. | 2010
- S422
-
1093 ANTI-a ACTININ ANTIBODIES ARE INDEPENDENT PREDICTORS OF RESPONSE TO TREATMENT IN AUTOIMMUNE HEPATITIS TYPE 1Zachou, K. / Renaudineau, Y. / Chauveau, A. / Youinou, P. / Dalekos, G. N. et al. | 2010
- S424
-
1098 MODELLING HEPATIC OSTEODYSTROPHY: BALB-ABCB4 KNOCKOUT MICE LACKING THE HEPATOBILIARY PHOSPHOLIPID TRANSPORTER DISPLAY DECREASED 25-OH-VITAMIN D3 SERUM LEVELS AND BONE MINERAL CONTENTSHochrath, K. / Krawczyk, M. / Rathkolb, B. / Micklich, K. / Hans, W. / Adler, T. / Wang, Y. / Fuchs, H. / Gailus-Durner, V. / Busch, D. H. et al. | 2010
- S425
-
1101 INCIDENCE AND CLINICAL RELEVANCE OF ANTIBODIES TO THE BETA- AND GAMMA SUBUNITS OF THE F1F0-ATPASE IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS (PBC)Nann, D. / Preu, B. E. / Berg, C. P. / Gregor, M. / Klein, R. et al. | 2010
- S426
-
1104 DYSREGULATION OF GAL-9/TIM3 PATHWAY MIRRORS T-REG IMPAIRMENT IN AUTOIMMUNE HEPATITISLiberal, R. / Ma, Y. / Mieli-Vergani, G. / Vergani, D. / Longhi, M. S. et al. | 2010
- S428
-
1109 POSITIVE ANTI-GP210 ANTIBODIES IS A STRONG RISK FACTOR FOR BILE DUCT LOSS AND HEPATITIS WHICH INDUCE JAUNDICE-TYPE PROGRESSION OF PRIMARY BILIARY CIRRHOSIS IN JAPANESE PATIENTSNakamura, M. / Ito, M. / Yamamoto, K. / Zeniya, M. / Ohira, H. / Hashimoto, E. / Kaneko, S. / Ueno, Y. / Kikuchi, K. / Onji, M. et al. | 2010
- S430
-
1114 FUNCTIONAL CHARACTERIZATION OF THE SEMI-SYNTHETIC BILE ACID DERIVATIVE INT-767, A DUAL FXR AND TGR5 AGONISTRizzo, G. / Passeri, D. / De Franco, F. / Ciaccioli, G. / Sadeghpour, B. / Pellicciari, R. / Pruzanski, M. / Adorini, L. et al. | 2010
- S431
-
1117 LOW-DOSE ATORVASTATIN IMPROVES DYSLIPIDEMIA AND VASCULAR FUNCTION IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS AFTER ONE YEAR OF TREATMENTStojakovic, T. / Claudel, T. / Putz-Bankuti, C. / Fauler, G. / Scharnagl, H. / Wagner, M. / Sourij, H. / Stauber, R. E. / Winkler, K. / Marz, W. et al. | 2010
- S432
-
1120 BICARBONATE SECRETION OF MOUSE CHOLANGIOCYTES INVOLVES Na+-HCO3- COTRANSPORT IN ADDITION TO Na+-INDEPENDENT Cl-/HCO3- EXCHANGEUriarte, I. / Banales, J. M. / Saez, E. / Arenas, F. / Elferink, R. P. / Prieto, J. / Medina, J. F. et al. | 2010
- S433
-
1123 PROTEIN KINASE C MEDIATED ENDOCYTOSIS OF SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE (NTCP) AS A PROTECTIVE MECHANISMWeissenberger, K. / Stross, C. / Helmer, A. / Keitel, V. / Haussinger, D. / Kubitz, R. et al. | 2010
- S434
-
1126 NONINVASIVE IMAGING FOR DIAGNOSING ABSENCE OF BILIARY COPPER EXCRETION IN WILSONS DISEASEBahde, R. / Kapoor, S. / Bhargava, K. K. / Palestro, C. J. / Gupta, S. et al. | 2010
- S436
-
1131 ANALYSIS OF GENE EXPRESSION ASSOCIATED TO HEPATOCARCINOMA DEVELOPMENT IN LIVER TISSUE OF THE FAH-/- MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE 1Orejuela, D. / Tanguay, R. M. et al. | 2010
- S437
-
1134 AAV MEDIATED LIVER GENE THERAPY PROVIDES PROLONGED ENZYMATIC CORRECTION AND PROTECTS AGAINST INDUCED MOTOR NEUROPATHY IN ACUTE INTERMITTENT PORPHYRIA MICEUnzu, C. / Sampedro, A. / Mauleon, I. / Alegre, M. / Beattie, S. / de Salamanca, R. E. / Twisk, J. / Timmermans, E. J. / Hernandez-Alcoceba, R. / Melero, I. et al. | 2010
- S438
-
1136 THE AMOUNT OF ALCOHOL CONSUMPTION NEGATIVELY IMPACTS SHORT-TERM MORTALITY IN PATIENTS WITH ALCOHOLIC HEPATITIS: CLINICAL IMPLICATIONSAltamirano, J. / Higuera, F. / Duarte-Rojo, A. / Abraldes, J. G. / Martinez, M. / Herrera, L. / Zapata, L. / Perez, J. L. / Torre, A. / Gonzalez, J. A. et al. | 2010
- S440
-
1139 ABNORMALLY ELEVATED SERUM FREE LIGHT CHAINS IN PATIENTS WITH LIVER DISEASEAssi, L. K. / Hughes, R. G. / Gunson, B. / Webb, G. M. / Drayson, M. T. / Bradwell, A. R. / Adams, D. H. et al. | 2010